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ABSTRACT
How Subjective and Objective Memory, Family History, and Knowledge
of Alzheimer’s Disease Influence Older Adults’
Fear of Developing Alzheimer’s Disease
by
Samantha Lyn French
Dr. Karen Kemtes, Examination Committee Chair
Assistant Professor o f Psychology
University o f Nevada, Las Vegas
It is projected that by the year 2050, the number o f Americans with Alzheimer’s
disease (AD) will rise to approximately 13.2 million. And, because AD is on the rise,
apprehension about developing the degenerative disease (anticipatory dementia or fear of
developing AD) has become a topic of study in the past few years. However, most
studies focusing on anticipatory dementia have used a sample o f individuals younger than
age 65 and have used a single item questionnaire to explore their apprehension. The
current study utilized 50 adults ages 65 and older to examine anticipatory dementia and
its relationship with subjective and objective memory, family history, and knowledge of
AD. Fear of developing AD was assessed using a new 30-item, psychometrically sound
instrument titled the Fear o f Alzheimer’s Disease Scale (FADS). Results o f the study
revealed that: (1) in-line with existing research, subjective memory complaints was
positively associated with fear o f developing AD, (2) family history, knowledge o f AD,
and objective memory were not significantly correlated with fear o f developing AD, (3)
subjective memory was the only significant predictor o f fear of developing AD; neither
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family history, knowledge of AD, nor objective memory predicted fear of developing the
disease, (4) knowledge o f AD was not associated with anxiety, (5) there was no
significant relationship between subjective and objective memory, and (6) the
relationship between subjective memory and fear o f developing AD was still significant
after controlling for participants’ negative mood.
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CHAPTER 1

INTRODUCTION
“It’s not me currently with Alzheimer’s disease. But any time I misuse a
word, forget a name I have and should have known, momentarily lose the
car in a parking lot, I scare the bergeebers out of me! I fear becoming a
victim o f Alzheimer’s disease,..” (as cited in Cutler & Hodgson, 2001).
The Bureau of the Census (2005) reports that there are approximately 35.9 million
people 65 years and older currently living in the United States. It is projected that in
twenty-five years the number of elderly will reach 72 million. Additionally, there are 4.5
million Americans with Alzheimer’s disease. This number is expected to dramatically
increase to 13.2 million by the year 2050 (Hebert, Scherr, Bienias, Bennett, & Evans,
2003).
Alzheimer’s disease (AD) is a degenerative disease affecting predominantly
individuals over the age o f 60 and in rare cases, individuals as young as 30 (Small et al.,
1997). The onset of AD is gradual, but the progression is continuous. Early symptoms
of AD are often overlooked, being attributed to normal aging. “Senility,” and/or normal
aging are not as severe or as progressive as AD, however. Symptoms o f AD include
memory impairment, which is typically one o f the earliest symptoms, aphasia, apraxia,
agnosia, and executive functioning impairment (APA, 2000).
Currently there is no test that can diagnose AD; diagnosis can only be confirmed
postmortem through autopsy. However, when Alzheimer’s disease is suspected, several
tests can be conducted to increase the likelihood of an accurate diagnosis. These tests

may include, but are not limited to, computed tomography (CT), magnetic resonance
imaging (MRI), blood tests, lumbar puncture, neuropsychological evaluation, officebased clinical assessment, and an informant interview (APA, 2000; Small et ah, 1997). If
a diagnosis o f AD is made, there are several pharmacotherapy options that can help slow
the progression o f the disease. Presently there is no cure for AD. It is, however,
extremely important to detect AD early and accurately so that medication can be taken
while symptoms are still mild, costs associated with AD can be reduced, and families can
prepare for the challenges that may lay ahead (Small et al., 1997).
Alzheimer’s disease is becoming an increasing health concern due to the recent rise in
the number o f dementia cases. And, the fact that genetics can play a large role in the
development o f AD and other dementias, especially in individuals having family
members diagnosed with early-onset AD (Heston, 1991; Swearer, O ’Donnell, Parker,
Kane, & Drachman, 2001), there may be cause for more concern among those with a
family history o f the disease. For these and many other reasons, apprehension about
developing the degenerative disease has become a topic o f studies in the past few years.
There have been relatively few studies, however, looking at the relationship between tear
of developing AD and other variables, namely subjective memory, objective memory,
family history o f Alzheimer’s and other dementias, and knowledge o f Alzheimer’s
disease.
For some people, experiencing a memory problem may evoke thoughts o f developing
AD or another type o f dementia. Thoughts for this group o f people are usually only
fleeting. They generally do not take the idea very seriously nor do they allow it to cause
much distress. However, for other people, experiencing episodes o f forgetfulness can

lead to significant distress and worry about developing AD (Ponds, Commissaris, &
Jolies, 1997). In 1996, Cutler and Hodgson described a phenomenon termed
“anticipatory dementia,” that explains these latter individuals. Anticipatory dementia is
the basic fear that normal memory problems associated with aging are an indication of
dementia. One study revealed that approximately 92% o f individuals with a parental
history o f AD experienced anticipatory dementia (Cutler & Hodgson, 2001).
Anticipatory dementia is a relatively new concept and there is much to learn about it.
For this reason, we have generated several hypotheses related to fear o f developing AD
that are based upon results and limitations o f prior studies.
1. Subjective memory complaints, family history of AD, and knowledge of AD will
be positively correlated with fear o f developing AD. Objective memory will not
be correlated with fear o f developing AD.
2. Subjective memory complaints, family history, and knowledge of AD will
significantly predict fear o f developing AD. Subjective memory complaints will
emerge as the best predictor of fear o f developing AD followed by family history
and knowledge o f AD. Family history o f AD and knowledge o f AD will emerge
as predictors which offer unique contributions to predicting fear o f developing
AD above and beyond subjective memory. Objective memory will not
significantly predict fear o f developing AD.
3. Knowledge o f AD will be positively correlated with levels o f anxiety.
4. There will be no significant relationship between subjective memory complaints
and objective memory.

5. The relationship between subjective memory complaints and fear o f developing
AD will be significant even after controlling for negative mood.

CHAPTER 2

LITERATURE REVIEW
Fear of Developing Alzheimer’s Disease
The onset of symptoms consistent with certain diseases is disconcerting for many
individuals. While some studies have addressed concern about developing specific
diseases with genetic underpinnings like Huntington’s disease (Hunt & Walker, 1991)
and hypertrophic cardiomyopathy (Siebert, 1995), relatively few studies have looked at
the fear associated with developing AD.
The first study evaluating older adults’ fear of developing AD was performed in 1986
(Price, Price, Shanahan, & Desmond, 1986). Researchers found that 84% o f participants
described their perceptions of developing AD using words such as “concerned” (24%),
“frightened” (22%), “scared stiff’ (20%), and “worried” (19%). Researchers noted that
at least one participant made the following comment: “I would rather have cancer than
Alzheimer’s” (Price et al., 1986, p. 420).
Researchers in the Netherlands also found that individuals were afraid o f developing
AD. While conducting informational meetings about the differences between normal
forgetfulness and dementia, Commissaris and colleagues found that 46% o f individuals
reported attending the informational meetings because they were worried about tbeir
memory and incipient dementia (Commissaris, Verhey, Jr., Ponds, Jolies, & Kok, 1994).

Although the previous studies were influential in introducing the new research area of
fear o f developing AD, it w asn’t until Cutler and Hodgson’s studies were published that
research on the topic became recognized. In 1996, Cutler and Hodgson coined the term,
“anticipatory dementia,” to refer to the concern individuals have about age-associated
memory impairments being indicative o f AD. Since 1996, Hodgson and Cutler have
published five articles that look at the relationship between anticipatory dementia and
other variables (Cutler & Hodgson, 1996; Cutler & Hodgson, 2001; Hodgson & Cutler,
1997; Hodgson & Cutler, 2003; Hodgson, Cutler, & Livingston, 1999).
Cutler and Hodgson (1996) hypothesized that memory problems, once associated
with normal aging, now cause fear, and are being seen as early symptoms o f AD or other
dementias. Their hypothesis was accurate. Using a single question (i.e., “I ’d like to ask
how concerned you are about personally developing Alzheimer’s disease. Would you
say you are very concerned, somewhat concerned, not very concerned, or not at all
concerned about developing A lzheimer’s?” ), to measure anticipatory dementia, they
found that 10% o f participants were “very concerned,” 44% were “somewhat concerned,”
32% were “not very concerned,” and 14% were “not at all concerned."
After determining that anticipatory dementia was, in fact, a valid fear for adults,
Hodgson and Cutler (1997) explored the construct further by examining its relationship
with well-being, as measured by life satisfaction, depression, psychiatric
symptomatology, and self-reported health status. Researchers found that, for participants
with a family history of AD, life satisfaction was significantly related to anticipatory
dementia. In the control group (i.e., no family history o f AD), a significant relationship
was found between anticipatory dementia and both psychiatric symptomatology and self

reported health. Hodgson and Cutler (1997) concluded that individuals experiencing
anticipatory dementia may perceive their lives more negatively than those who do not
fear developing AD.
To further explore fear of developing AD, Hodgson et al. (1999) examined
anticipatory dementia in both individuals with a family history o f AD and those without a
family history. Using their single-item question, they found that individuals with a
family history o f AD exhibited high levels o f symptom-seeking behavior in addition to
reporting anxiety about developing the disease: 67% reported being “very” or
“somewhat” concerned while only 40% of controls reported being “very” or “somewhat”
concerned. Additionally, controls were unlikely to report symptom-seeking behavior.
Based upon the results, the researchers suggested that individuals having parents with AD
search for AD symptoms as a result of experiencing anticipatory dementia.
In 2001, Cutler and Hodgson, conducted a follow-up study to their 1996 study and
found similar results. Ninety-two percent o f participants who had a parent with AD
reported being either “very” or “somewhat” concerned about developing AD. In the
matched control group, only 47% of the participants expressed the same concern.
In their last study, to date, Hodgson and Cutler (2003) examined symptom-seeking
behavior in both individuals with a family history o f AD and in those without a family
history. Results were similar to those found in their 1999 study: a significant relationship
existed between symptom-seeking behavior and anticipatory dementia.
The research conducted by Cutler, Hodgson, and colleagues (Cutler & Hodgson,
1996; Cutler & Hodgson, 2001; Hodgson & Cutler, 1997; Hodgson & Cutler, 2003;
Hodgson et al., 1999) expanded the modest literature on anticipatory dementia. Although

influential, the research was not flawless. All o f their research utilized individuals
between the ages of 40 and 60. Although this is an important age group to assess, these
individuals are not in the typical age range for the development o f AD. One would
conjecture that tear o f AD would increase as the age o f onset approaches. Therefore,
assessing individuals after the typical age o f onset (i.e., 65 years and older), may reveal
distinct tear.
Cutler, Hodgson, and colleagues’ other major flaw resided in their methodology. In
assessing anticipatory dementia, all o f their studies utilized a single-item question: “I ’d
like to ask you how concerned you are about personally developing Alzheim er’s disease.
Would you say you are very concerned, somewhat concerned, not very concerned, or not
at all concerned about developing Alzheimer’s?” A single-item questionnaire threatens
reliability and validity. A multiple-item questionnaire would not only reduce these
threats, but would both better describe and better predict individuals’ fear o f developing
AD.
During the time that Cutler, Hodgson, and colleagues were conducting various
studies, other researchers began investigating the new field o f anticipatory dementia as
well. Reese, Cherry, and Norris (1999) addressed “memory fears” in older-adults. To
measure “memory fears,” eight questions were asked pertaining to “apprehensions that
one has about the ways that memory loss can affect one’s well-being and quality o f life”
(Reese et al., 1999, p. 233). The most frequent apprehension reported was the fear of
losing one’s independence. Participants also reported fear that they would inaccurately
represent their memories. The third most frequent response was fear o f developing
dementia.

Roberts and Connell (2000) conducted a study that looked at attitudes, beliefs, and
experiences regarding AD. Their research revealed that 74.3% o f participants thought
they would develop AD within their lifetime. Over half o f the participants (52.2%)
expressed concern over developing AD. And, 34.5% reported being more concerned
about developing AD than another health problem.
To add to the anticipatory dementia literature, Werner (2002) conducted a study that
looked at individuals without a family history o f AD and their concerns about developing
the disease. Twelve percent of participants reported no concern while 46% reported
being very concerned about developing AD.
Laforce and McLean (2005) studied fear and knowledge o f AD among young and
older adults. Their sample consisted o f 127 young adults ages IBABO years and 119 older
adults ages 55 to 90 years. To measure fear and knowledge o f AD, a 40-item
questionnaire designed specifically for the study was administered to participants. O f the
40 questions, only one question was devoted to measuring fear o f AD: “How afraid are
you o f developing Alzheimer’s Disease?” Participants rated their fear on a 5-point Likert
scale ranging from “not at all” to “very afraid.” Younger participants’ fear o f developing
AD was significantly higher than that o f the older adults.
To address the paucity o f questions used to measure tear o f AD, French (2005)
created a scale, titled the Fear o f Alzheimer’s Disease Scale (FADS), to assess older
adults’ tear o f developing AD. The FADS is a 30-item self-report measure used to assess
anticipatoiy dementia across three different dimensions: older adults’ basic and
metamemory based tear o f developing AD (General Fear), physical symptoms that older
adults experience due to tear o f developing AD (Physical Symptoms), and older adults’

catastrophic thinking associated with fear of developing AD (Catastrophic Attitude).
Participants indicate their level of agreement with the statement using a 5-item Likerttype scale ranging from “never,” to “always.”
Researchers administered the FADS to 101 older adults ages 65-91. Results o f the
study illustrated that the FADS is a reliable and valid instrument in the evaluation of fear
o f developing AD among older adults. It is the first scale with good psychometric
properties available to directly address fear o f developing AD (French, 2005).
In addition to determining the psychometric properties of the FADS, French (2005)
also found that both family history and subjective memory were significant predictors of
fear o f developing AD while objective memory was not a significant predictor. The
research confirmed prior findings; older adults are afraid of developing AD. However,
by using a 30-item questionnaire researchers were able to determine what specifically
older adults were afraid o f (e.g., losing their independence, not recognizing family
members) rather than simply determining that the fear, in fact, exists.
In summary, previous research has found that individuals are afraid o f developing
Alzheimer’s disease. Only one study to date, however, has assessed this fear among
older adults utilizing a multiple-item questionnaire (French, 2005). In this study, the
researchers demonstrated that a multiple-item questionnaire may both better describe and
better predict individuals’ fear of developing AD compared with a single-item question
about such fear. The current study hopes to address older adults’ fear o f developing AD
and the relationship between this fear and subjective memory, family history o f AD,
knowledge o f AD, and objective memory.
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Relationship between Fear o f Developing AD and Subjective Memory Complaints
Subjective memory, or metamemory as it is also commonly known, has been
researched extensively, especially in the elderly population. It is “the knowledge one
possesses about the functioning, development, use, and capacities o f the human memory
system in general, and one’s own memory in particular” (as cited in Dixon & Hultsch,
1983, p. 689).
Subjective memory complaints are common among the elderly, and refer to the
awareness an individual has about his/her own memory decline. Many researchers have
examined subjective memory complaints in an attempt to determine if complaints
indicate the beginning o f Alzheimer’s disease or other forms o f dementia. To examine
subjective memory complaints, a variety o f questionnaires have been used. Some
researchers use a single-item question, while others employ lengthy measures. Whereas
many studies have looked at the relationship between subjective memory complaints and
objective memory, only five studies to date have looked at the relationship between
subjective memory complaints and fear o f developing AD.
Cutler and Hodgson (1996) looked at the relationship between anticipatory dementia
and subjective memory. To measure subjective memory, they used the Short Inventory
o f Memory Experiences (SIME; Herrmann, 1984), which consists of 24 items pertaining
to experiences with memory. Additionally, they used six questions developed
specifically for the study to measure subjective memory: four were closed-ended items
and the other two were open-ended questions. The composite score from the six
questions resulted in the Memory Assessment Index (MAI; Cutler & Hodson, 1996). The
researchers found that subjective memory and anticipatory dementia were related.
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Specifically, negative assessments o f one’s memory were related to greater concern about
developing AD. Contrary to one of their hypotheses. Cutler and Hodgson did not find a
difference between participants with family history and participants without family
history with regard to the relationship between subjective memory and fear of developing
AD. They did, however, discover that participants having a parent with AD were more
fearful about developing AD than participants having no family members with either AD
or another dementia.
Similar to their 1996 study, Cutler and Hodgson (2001) used the SIME and several
ratings o f memory functioning to assess subjective memory. They found that subjective
memory complaints played a large role in fearing the development o f AD in both
participants with a family history of AD and in participants without a family history of
AD. Furthermore, participants whose parents developed AD expressed far more concern
over developing the disease than individuals without a family history o f AD.
In addition to researching symptom-seeking behavior, Hodgson and Cutler (2003)
looked at the relationship between subjective memory and anticipatory dementia. To
measure subjective memory, they used the SIME and several questions pertaining to
memory functioning. The researchers found that subjective memory and anticipatory
dementia were significantly related.
Werner (2002) also examined the relationship between subjective memory and fear o f
developing AD. To assess subjective memory, she asked three questions about whether
the individual had problems remembering things, names o f relatives, and/or times and
places. The questions were rated on a 4-point Likert-type scale ranging from “not at all”
to “very frequently”. A composite score was determined from the three questions.
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Results revealed that the most significant predictor o f anticipatory dementia was
worrying about their memory problems. This finding was consistent with Cutler and
Hodgson’s studies (1996 & 2001).
To add to the scant literature, French (2005) looked at the relationship between tear
of developing AD and subjective memory. Researchers utilized the 30-item Fear o f
Alzheimer’s Disease Scale (FADS; French, 2005) to assess older adults’ tear o f
developing AD, and the 64-item Memory Functioning Questionnaire (MFQ; Gilewski &
Zelinski, 1986) to examine subjective memory. Like Werner (2002), they found that
subjective memory was a significant predictor o f fear o f developing AD.
All studies, to date, have found a significant relationship between subjective memory
and tear of developing AD. Two o f these studies used a more powerful statistical
analysis (i.e., multiple regression) to show that, not only does a significant relationship
exist between subjective memory and fear o f developing AD, but that subjective memory
significantly predicts this fear; individuals who believe their memory is poor are more
likely to tear developing AD than individuals who believe their memory is normal or
above average. Based upon results from the literature, the current study is hypothesizing
that subjective memory complaints will significantly predict tear o f developing AD.
The current study is using an elderly population to look at fear o f developing AD.
The majority of studies examining anticipatory dementia looked at middle-age
individuals. And, while they found significant results, it seems logical that, because the
likelihood of developing AD dramatically increases after the age o f 65 (Fairer,
O ’Sullivan, Guppies, Growdon, & Myers, 1989), elderly individuals would be even more
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fearful o f developing AD than middle-aged individuals based purely upon the probability
of them developing the disease.
Relationship between Fear o f Developing AD and Family History o f AD
“Whenever I asked about the cause [of AD], I tried to look nonchalant,
because by this point, every time I lost my keys or forgot someone’s first
name, I thought that the disease was in the blood” (as cited in Hodgson et
ak,1999X
AD was thought to have a genetic component as early as 1929 (as cited in Farrer,
1997). Since then, hundreds of studies have attempted to identify which genes play a role
in the development of AD. More specifically, researchers have attempted to identify
specific genes associated with both early-onset AD (diagnosis occurring before age 65)
and late-onset AD (diagnosis occurring after age 65).
Individuals with early-onset AD account for a relatively small number of AD cases.
It is an autosomal dominant transmitted disease that has been associated with four genes
to date. Specifically, it has been linked with mutation at codons 670, 671, and 717 of the
beta-amyloid precursor protein (APP) gene located on chromosome 21 (Goate, et al.,
1991; Murrel, Farlow, Ghetti, & Benson, 1991), and the SMT2 gene located on
chromosome 1 (Levy-Lahad, et al., 1995). More commonly, individuals with early-onset
AD show a mutation on the AD3 gene located on chromosome 14 (Goate, et al., 1991;
Schellenberg, et al., 1992; Sherrington, et al., 1995; St George-Hyslop, et al. 1992), or on
the Apolipoprotein E (ApoE) gene, which is the most researched gene linked with both
early- and late-onset AD. Because the current sample is comprised o f individuals aged
65 and older, consequently falling into the late-onset AD category, research pertaining to
the ApoE gene and its association with late-onset AD will be discussed in greater detail
than the genes associated with early-onset AD.

14

ApoE is a plasma protein with 3 common alleles (allele-2, allele-3, and allele-4)
encoded on chromosome 19. These 3 alleles correspond to 6-phenotypes (2/2, 3/3, 4/4,
2/3, 2/4, 3/4). Initially, it was thought that ApoE-4 occurred disproportionately more in
individuals diagnosed with late-onset AD than in controls (Saunders, Strittmatter,
Schmechel, 1993; Strittmatter et al., 1993). More recent studies, however, have revealed
that ApoE-4 is more common in not only late-onset AD, but in early-onset AD as well
(van Duijn et al., 1994).
Most molecular and epidemiological genetic studies determine the risk o f developing
AD by calculating an odds ratio (OR). To calculate an OR, researchers determine the
population with AD (d), and the number o f cases without AD (n), yielding an odds ratio
of d/n (Jorm, 1990).
In 1997, Farrer et al. conducted a meta-analysis that looked at the relationship
between the ApoE genotype and AD. Farrer and his colleagues compiled data from 40
out o f 48 possible research groups, representing a total of 5930 patients with probable or
definite AD and 8607 controls without dementia. Researchers found the ORs for
Caucasian participants from clinic and autopsy based studies to be as follows; (1)
participants with genotype 2/4 revealed an OR equal to 2.6 (95% confidence interval =
1.6-4.0), (2) for participants with 3/4, the OR equaled 3.2 (95% Cl = 2.8-3.8), and (3) for
4/4, the OR was 14.9 (95% Cl = 10.8-20.6). For participants with genotypes 2/2 and 2/3,
ORs were decreased (OR=0.6, 95% Cl == 0.2-2.0 and O R -0.6, 95% Cl = 0.5-0.8
respectively). The results suggest that there is a significant relationship between ApoE-4
and AD. Other research supports this finding as well (Corder et al., 1993; Hall et al.,
1998; Massaia et al., 2001):
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Epidemiological studies are another approach when looking at family history o f AD.
In 1989, St. George-Hyslop and his colleagues did a review o f the literature on
epidemiological studies. The researchers investigated family history o f AD using three
approaches: (1) family studies in which pedigrees were analyzed (2) twin studies, and (3)
survey studies where a variety of methods and test populations from various studies were
compiled.
At the time of the review, 88 families reporting familial AD had been discussed in the
literature. Out o f the 88 pedigrees, family members developing AD equaled 48.6%. In
order for a trait to be considered solely an autosomal dominant trait, the proportion o f
individuals affected with a particular disease must equal 50%. Results from the literature
suggest that, although the percentage o f AD cases did not equal the 50% level, it did
approximate the percentage expected. St. George-Hyslop et al. (1989) discussed
limitations of the family studies investigated in their review. Namely, only 26 o f the 88
families tested were able to provide sufficient evidence for AD being an autosomal
dominant trait. The other 62 did not have enough family members affected in multiple
generations to support the notion of AD being an autosomal dominant trait.
Nevertheless, while determining whether or not AD is an autosomal dominant trait is
important, the fact remains that almost 50% o f individuals with a family history o f AD
developed the disease at some point in their lifetime indicating a strong genetic
component.
A review o f twin studies revealed that 32 monozygotic (MZ) twin pairs and 7
dizygotic (DZ) twin pairs, with at least one individual in the pair being afflicted with AD,
had been studied at the time of the review. Concordance rates were 44% for the MZ pairs
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and 40% o f the DZ pairs. Additionally, age of onset differed in MZ concordant twin
pairs. These results are worth comparing to Huntington disease (HD), a purely autosomal
dominant trait. In twin studies o f HD, concordance rates for MZ pairs equals 100%.
Additionally, the age of onset in HD twin pairs is very similar. Results from the AD twin
studies suggest that AD is not a fully autosomal dominant trait; it may be caused by other
genetic and environmental factors. Results from the AD twin studies should be
interpreted with caution since the number o f twin pairs studied was extremely small.
Survey studies are more accurate in looking at family history o f AD because o f their
ability to determine both the likelihood o f developing AD among relatives of AD patients
and the ratio o f AD revealing familial aggregation (St. George-Hyslop et al., 1989). In
their review o f survey studies, St. George-Hyslop and his colleagues found that, in earlier
studies, increased risk to parents (10-14.4%) and siblings (3.8-13.9%) o f AD patients was
significant, yet somewhat unconvincing. More recent studies, using Kaplan-Meier life
table methods, show more substantial results: (I) the likelihood o f developing AD among
first degree relatives o f controls was 10%, (2) the likelihood increased to 50% when the
individual has a first degree relative with AD. Results suggest an autosomal dominant
trait. O f the six survey studies reviewed, only one found conflicting results (Fairer, O ’
Sullivan, Guppies, Growdon, & Myers, 1989).
Additional epidemiological studies have found that family history greatly contributes
to an individual’s increased risk of developing AD. In case-controlled studies, the risk of
developing AD ranged from 39% to 64.3% in those with a family history o f the disease
(Farrer et al., 1990; Lautenschlager et al., 1996; Massaia et al., 2001; Van Duijin, Farrer,
Guppies, & Hofman, 1993). Researchers using ORs found that the risk ranged from 2.62
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to 13.0 (Broe & Henderson, 1990; Canadian Study o f Health and Aging, 1994; Li et al.,
1992; Prince, Cullen, & Mann, 1994; Salih, 2000).
Only one study found contradicting results. Launer et al. (1999) performed a meta
analysis o f four European population-based studies. They found a nonsignifieant
increased risk of 1.6 for developing AD in individuals with two or more first degree
relatives with the disease.
When looking speeifically at tear of developing AD and family history, studies have
shown that tear of developing AD tends to be greater when there is a family history of the
disease (Cutler & Hodgson, 1996; Cutler & Hodgson, 2001). This fear ean be further
heightened when the individual’s family member developed early-onset AD or when
he/she has two parents with AD (Birkett, 1989).
Freneh (2005) explored the relationship between family history o f AD and fear of
developing AD among older adults. Rather than using a eorrelational design, however,
the study again used a more powerful statistieal analysis (i.e., multiple regression) to
show that family history of AD significantly predicted fear of developing AD. Results
signified that individuals with a family history are more afraid o f developing the disease
than individuals without a family history. Again, Freneh’s study allowed researchers to
not only explore the relationship between family history of AD and fear o f AD, but the
many facets o f the tear as well.
Based upon genetie studies and other studies that have addressed the relationship
between family history o f and fear o f AD, the current study is hypothesizing that family
history o f AD will be a signifieant predictor o f anticipatory dementia.
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Relationship between Knowledge o f AD and both Fear o f Developing AD and Anxiety
“A lot o f knowledge can be a bad thing.. .sometimes people get scared of
knowing too much.”
- Man with Cystic Fibrosis
(Chapman & Bilton, 2004, p. 369)
As evidenced by the above quote, sometimes knowledge can be scary. However,
very few studies have investigated the relationship between fear o f developing AD and
knowledge o f AD. Commissaris and colleagues (1994) were one o f the first to address
this relationship. Researchers eondueted informational meetings to edueate individuals
on the differences between normal forgetfulness and dementia. Four hundred-fifty
attended the meetings. O f the 450, 246 participants completed both pre-test and post-test
questionnaires. The average age o f participants was 58 years. To assess knowledge o f
AD, partieipants were asked 5 questions as both baseline and follow-up. Additionally,
participants answered “yes” or “no” regarding whether or not they were afraid of
dementia. Sixty-six percent of individuals that were afraid o f their memory and ineipient
dementia were reassured after attending the meetings. However, contrary to researchers’
hypothesis, there was no correlation found between increased knowledge and anxiety
about developing dementia.
Commissaris and eolleagues (1995) eondueted another study looking at the effeet of
knowledge on eoneern about dementia. In their previous study, they eondueted
informational meetings about the differences between normal forgetfulness and dementia.
The current study utilized an informational brochure to educate individuals on this
difference. Approximately 475 men and women participated in the study (M age = 66
years). At baseline, 25% o f individuals reported being “very mueh eoneemed” about
dementia, 52% reported “little coneem” and 23% reported “hardly any/no concern.”
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After reading the brochures, 77% o f individuals reporting “much concern” said their
concern decreased substantially. Researehers eoncluded that informational brochures on
the differences between normal forgetfulness and dementia can help reduce individuals’
fear about developing dementia.
Commissaris and colleagues’ (1995) study provides useful information about the
relationship between knowledge o f AD and fear o f developing dementia. However, they
did not utilize a questionnaire to assess knowledge. They assumed that after reading the
informational broehure about the differences between normal forgetfulness and dementia,
individuals would be more knowledgeable about dementia. It is necessary to have both
pre and post-tests to confirm this assumption. Additionally, both studies performed by
Commissaris and colleagues (1994 & 1995) addressed fear o f dementia utilizing a single
question. As French (2005) demonstrated, a multiple-item questionnaire provides a
better measurement o f individuals’ fear o f developing AD.
LaForce and McLean (2005) utilized a 40 item questionnaire specifically designed to
assess fear of developing AD and knowledge o f AD. Participants answered questions
about general knowledge, risk faetors, cognition, and personality with regard to AD. As
with previous research, only one question expressly addressed participants’ fear of
developing AD. Results of the study revealed that younger individuals (M age - 19.6,
SD = 3A ) knew more about AD than older individuals (M age = 67.9, SD = 7.9).
Covariance analysis indicated that the differences between the groups could not be
accounted for by edueation. Additionally, the younger adults were more fearful o f
developing AD than older adults. Researchers concluded that the more knowledge
individuals have about AD, the more fearful o f the disease they are.
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Although LaForce and McLean (2005) added to the pre-existing literature, the
relationship between fear o f developing AD and knowledge o f AD needs to be further
addressed. Specifically, much like other researchers, LaForce and M cLean questioned
participants about their tear using a single question. As explained previously, using a
single item to address this construct possess a threat to validity and reliability.
Additionally, it does not address the various aspects o f fear o f developing AD. The
relationship between fear of AD and knowledge o f AD should be examined using
psyehometrieally sound instruments that incorporate multiple questions.
The previous studies specifically address how knowledge affects individuals’ concern
about AD or dementia. Other researchers, however, have addressed the relationship
between knowledge o f dementia using a more generic construct, anxiety. And, even
though these studies do not assess fear of developing AD directly, previous research has
shown that anxiety and fear of developing AD are significantly correlated (French, 2005).
Graham, Ballard, and Sham (1997a) examined the relationship between knowledge of
dementia and anxiety among 109 caregivers of dementia patients ages 65 and older.
Each participant was interviewed and administered the following assessment schedules
relevant to the current study: (1) the Geriatric Mental State Schedule (Copeland,
Kelleher, & Kellet, 1976) to assess psychiatric health; and (2) and the Dementia
Knowledge Questionnaire (Graham, Ballard, & Sham, 1997b) to assess caregivers’ level
of knowledge of dementia. Researchers found that caregivers possessing greater
knowledge o f dementia had significantly higher rates of anxiety.
Proctor, Martin, and Hewison (2002) also looked at the relationship between
knowledge about dementia and anxiety among caregivers. Fifty caregivers ages 65 and
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older agreed to participate in the study. Caregivers’ knowledge about dementia was
assessed using the Dementia Quiz (Gilleard & Groom, 1994) and their levels o f anxiety
were measured using the Hospital Anxiety and Depression Scale (HADS; Zigmond &
Snaith, 1983). The findings substantiated the research performed by Graham, Ballard,
and Sham (1997a). Proctor and colleagues (2002) found that there was a significant
relationship between increased knowledge and anxiety. Specifically, caregivers’
biomedical knowledge was predictive o f anxiety.
M edical Student Disease
The relationship between health knowledge and anxiety is not a new topic to
psychology. Medical Students’ Disease (MSD), also known as Medical Students’
Syndrome (MSS), nosophobia, and medicalstudentitis, is a construct that can be found in
the literature as early as 1945 (Wyler, 1945).
Woods and colleagues (1966) defined MSD as “the development o f either symptoms
or hypochondriacal anxiety about the disease being studied by the student” (p. 785). Two
studies concluded that approximately 70% to 80% o f medical students have a “positive
history” o f the disease at some point during their education (Hunter, Lohrenz,
Schwartzam, 1964; Woods, Natterson, & Silverman, 1966). Sixty-two percent o f
individuals believed that the cause o f their MSD was knowledge about the disease in
question.
Since 1945, many studies have examined MSD. Most studies revealed that, while
studying a particular illness, medical students focus on their bodily symptoms and falsely
believe that they have the latest “deadly” disease being studied (Candel & Merckelbach,
2003; Howes & Salkovskis, 1998; Hunter, Lohrenz, Schwartzam, 1964; Moss-Morris &
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Petrie, 2001; Woods, Natterson, & Silverman, 1966). Kellner, Wigging, & Pathak (1986)
found that, although medical students had an increased rate o f health related anxiety, it
was no different than that o f controls. Additionally, Singh and colleagues (2004) found
that medical students did not have higher levels of health anxiety. In fact, medical
students in years 1 and 4 had significantly lower health-related anxiety than controls.
Nonetheless, the majority o f research has substantiated the notion o f MSD.
Using the MSD concept, researchers have performed studies showing that MSD
affects non-medical individuals possessing increased levels o f knowledge as well.
Ferguson (1996) based his study on the notion o f MSD to hypothesize that the level o f
medical knowledge would be positively associated with the level o f hypochondriacal
concern. He assessed 40 female and 18 male undergraduate students (M age = 21.8
years, SD = 3.6). Ferguson found that the more individuals knew about disease etiology,
the more concerned they were about developing that disease.
The concept o f MSD was further broadened when Hardy and Calhoun (1997)
examined students’ perception of having a psychological disorder after learning about the
various mental illnesses in an Abnormal Psychology course. Researchers questioned 119
students enrolled in Abnormal Psychology (M age = 20.56, SD = 4.29) about their
concern over past and present psychological disorders in both themselves and family
members. Hardy and Calhoun (1997) found that concern about both their own and their
family members’ psychological health was fairly low. However, individuals either
majoring or planning to major in psychology reported significantly more concern about
psychological dysfunction than non-psychology majors. Additionally, individuals were
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more worried that someone in their family could be diagnosed with a personality
disorder.
Although the concept of MSD has not been applied to the relationship between
knowledge of AD and fear of developing the disease, it is not difficult to see that it could
be relevant; the more individuals know about Alzheimer’s disease, the more afraid they
become of developing it. Based upon the concept o f MSD and the previous literature
examining the relationships between knowledge o f AD and both fear o f developing AD
and anxiety, the current study is hypothesizing that knowledge o f AD will significantly
predict both fear of developing AD and anxiety.
Relationship between Fear o f Developing AD and Objective Memory
AD is heterogeneous in its symptomatology and course. Each individual experiences
AD somewhat differently. While one person may experience aphasia, for example,
another individual may not. Regardless o f the variants, however, everyone afflicted with
AD experiences memory problems. Whether using diagnostic criteria from the
International Classification of Diseases, 10''’ revision, (ICD-10; World Health
Organization, 1992), the Diagnostic and Statistical Manual o f Mental Disorders, d"’
edition, (DSM-IV-TR; APA, 2000) or the Neurological and Communicative Disorders
and Stroke - Alheimer’s Disease and Related Disorders Association (NINCDS-ADRDA;
McKhann, et al., 1984), one criteria remains constant; in order to be diagnosed with AD,
an individual must experience impairment in their memory.
Hundreds o f studies have looked at objective memory in individuals diagnosed with
AD. The ways in which researchers measure objective memory vary greatly. In general,
researchers use neuropsychological tests that assess short and long term memory.
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executive functioning, attention, temporal and spatial orientation, abstract reasoning,
constructional abilities, language deficits, and activities o f daily living (Bouchard &
Rossor, 1999; Mohr, Dastoor, & Claus, 1999).
Scores on objective memory assessments fluctuate depending upon the stage o f AD
that the patient is in. Neuropsychological evaluations reveal that, in the early stages of
dementia, many AD patients will experience difficulty with orientation, memory,
judgment, and word-finding. In the intermediate stages, the impairments present in the
early stages are amplified. Additionally, individuals with AD will begin having difficulty
with activities o f daily living. In the late stages, individuals are completely reliant upon
help from others; all autonomy is lost (Mohr et al., 1999).
An interesting observation has been made by many clinicians about distinguishing
pseudodementia from dementia. In pseudodementia, an individual generally presents in
the clinician’s office with subjective memory complaints. Typically the results of
objective tests, however, reveal no memory impairments. Individuals with true dementia
usually present in the clinician’s office with family members. The patient frequently does
not acknowledge experiencing any problems with memory. In fact, he/she may minimize
or ratiopalize the memory impairments. Yet, family members recognize that a problem
exists. In the case o f true dementia, objective assessments o f memory reveal an actual
problem with memory as opposed to pseudodementia cases where subjective memory
complaints are more prevalent than actual memory impairments (Bouchard & Rossor,
1999).
Because memory impairment is an essential criterion in the diagnosis o f AD, one
might conclude that objective memory would be highly related to fear o f developing AD.
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However, the researcher is hypothesizing that objective memory will not significantly
predict fear of developing AD. One reason for this hypothesis is that individuals
experiencing memory difficulties usually do not believe they have a problem with their
memory. Family members initiate the testing. Therefore, it would seem that they would
not be worried about developing it as much as if they had subjective memory eomplaints.
The hypothesis is also based on research pertaining to the relationship between subjective
and objective memory. Research has shown there to be a signifieant relationship between
subjective memory and fear o f developing AD. And, most studies found no relationship
existing between objective and subjective memory (see section titled “Relationship
between Objective and Subjective Memory in the Elderly”). Therefore, it seems logical
to deduce that, because subjective memory is hypothesized to significantly predict fear of
AD, objective memory would be hypothesized to not predict fear o f developing AD.
Although this relationship was directly assessed in only study, it was substantiated
(French, 2005).
French (2005) also looked at the relationship between objective memory and fear of
developing AD among older adults. To assess objective memory, the following tests
were administered; (1) Logieal Memory I & II from the W eehsler Memory Scale (WMSIII), (2) Digit Symbol-Coding from the Weehsler Adult Intelligence Scale (WAIS-III),
(3) Digit Span from the WAIS-III, and (4) the Abbreviated Boston Naming Test. A
composite score was created from these tests. The scores from each test were weighted
so that one test score did not influence the composite score more than any other score.
Results from the study revealed that, although subjective memory and family history
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significantly predicted fear o f developing AD, objective memory did not. The current
study is hoping to replicate these findings.

Relationship between Objective and Subjective Memory in the Elderly
Between the years 1967 and 2006, over 70 studies looking at the relationship between
objective memory and subjective memory have been published. It is a topic that has
caused much controversy due to its inconsistent findings. Researchers are still attempting
to determine whether or not individuals complaining of memory problems actually
exhibit impaired memory performanee.
Positive Relationship
Several studies have found a significant relationship between memory complaints and
performance on memory tests in older adults (Dixon & Hultseh, 1983; Gagnon et al.,
1994; Johansson, Allen-Burge, & Zarit, 1997; Jonker, Launer, Hooijer, & Lindeboom,
1996; Jonker, Lindeboom, & Hooijer, 1995; Riege, 1982; Wang et al., 2000; Zelinski,
Gilewski, & Thompson, 1980). This relationship was also found to be significant in
relatives of patients with early-onset AD (LaRue et al., 1996; McPherson, La Rue, Fitz,
Matsuyama, & Jarvik, 1995). Additionally, while Wang et al. (2000) found that
subjeetive memory did not prediet dementia, Johansson, Allen-Burge, & Zarit (1997) did
find that eomplaints about memory performanee over a 2-year period were predictive of
cognitive decline.
Weak/Modest Relationship
Several studies have found a positive, yet weak/modest relationship between
subjeetive and objective memory despite some efforts to reduee previous methodologieal
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problems (Hanninen et al., 1994; Hertzog, Park, Morrell, & Martin, 2000; Jorm et al.,
1994; MeDonald-Miszezak, Hertzog, & Hultseh, 1995; Sehmidt, Berg, & Deelman,
2001; Zelinski, Bumight, & Lane, 2001). Additionally, Hanninen et al. (1994) looked at
the relationship between depression and subjective memory. They found that the two
variables were not related. On the eonverse, Hertzog et al. (2000) found that depression
was signifieantly related to subjeetive memory.
Christensen (1991) and Bassett & Folstein (1993) found that the relationship between
subjeetive and objeetive memory varied by group. Christensen’s (1991) results revealed
that memory performanee was worse in elderly subjeets who believed their memory
impairment to be worse than other individuals o f their same age. Bassett and Folstein
(1993) diseovered that individuals expressing memory eomplaints were more likely than
individuals not eomplaining o f their memory to have impaired memory performanee.
Other researehers have found that, although there is a weak or modest relationship
between memory eomplaints and memory performanee, subjective memory is more
assoeiated with depression than with objeetive memory (Bolla, Lindgren, Bonaeeorsy,
Bleeker, 1991; O ’Hara, Hinriehs, Kohout, Wallaee, & Lemke, 1986).
No Relationship
An overwhelming number of studies have found no relationship existing between
memory eomplaints and memory performanee. One of the first o f these studies was
eondueted by Kahn, Zarit, Hilbert, & Niederehe (1975). Kahn and his eolleagues used
both psyehiatrie patients and relatives for eollateral information as partieipants. They
found that although there was no relationship between subjeetive and objeetive memory,
there was a strong positive relationship between subjective memory and depression.
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Other studies using non-demented individuals also found that there was no
relationship between objective and subjective memory (Best, Hamlett, & Davis, 1992;
Derouesne et ah, 1989; Flicker, Ferris, & Reisberg, 1993; French, 2005; McGlone et al.,
1990; O ’Connor, Pollitt, Roth, Brook, & Reiss, 1990; Rabitt & Abson, 1991; RiedelHeller, Matschinger, Sehork, & Angermeyer, 1999; Schofield et al., 1997; Sunderland,
Watts, Baddeley, & Flarris, 1986; Taylor, Miller, & Tinklenberg, 1992; Williams, Little,
Scales, & Blockman, 1987; Zarit, Cole, & Guider, 1981; Zelinski, Gilewski, & Schaie,
1993). Several o f these same studies found depression to be highly related to subjective
memory (Derouesne et al., 1989; McGlone et al., 1990; O ’Connor et al., 1990; Rabitt &
Abson, 1991; Sehofield et al., 1997; William et al., 1987). Conversely, Zarit et al. (1982)
found that mood had only a minimal relationship with subjeetive memory.
The results from studies looking at the relationship between memory appraisals and
memory performance are mixed. Few studies have found a positive significant
relationship. The majority o f studies on this topie have found either no relationship or a
weak/modest relationship.
It seems that the disparity in the data ean be attributed to the fact that subjective
memory is based upon some psychological aspect whereas objective memory is a pure
measurement o f memory without the intrusion of individuals’ personality/psychological
traits. While objeetive measures remain fairly stable aeross studies, measurement o f
subjeetive memory varies greatly. Some subjeetive memory questionnaires use a variety
o f questions, including those that address the psychological/personality eomponent of
memory eomplaints. Others use a single question. The way in which subjective memory
is measured could greatly affect the relationship between objective and subjective
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memory. Regardless of the reasons for the disparity in the literature, the inconsistencies
still exist. Based upon the majority of the results, the researchers hypothesize that there
will not be a signifieant relationship between subjeetive and objeetive memory.
Additionally, beeause many studies have shown there to be a significant relationship
between subjective memory and depression, it is possible that negative mood could
significantly impact the relationship between subjective memory and fear o f developing
AD. Only one study has addressed the effeets of negative mood on this relationship.
Freneh, 2005) found that the relationship between subjective memory performanee and
fear o f AD remained significant even after controlling for the effeets o f negative mood.
Based on these results and on the literature showing that subjective memory is
significantly correlated with fear o f developing AD, it is hypothesized that the
relationship between subjeetive memory and fear o f AD will remain significant even after
the effeets o f negative mood have been removed.
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CHAPTER 3

METHODS
Participants
The sample consisted of fifty, community dwelling, non-institutionalized, older adults
(24 males and 26 females) ages 65-84 (M = 72.24; SD = 5.37). O f the 50 participants, 5
were single, 26 were married, 11 were divorced, and 8 were widowed. The sample was
predominately Caucasian (92%) with African American (2%), Asian (4%), and Native
American (2%) individuals comprising the remainder. With regard to edueation, 4%
reported “some high sehool or less,” 14% “graduated high sehool or reeeived their GED,”
4% earned either a “technieal or associates degree,” 26% reported attending “some
college,” 20% received their “Bachelor’s degree,” 2% attended “some graduate sehool,”
14% earned their “M aster’s degree,” and 16% reported earning a “Doctoral degree (Ph.D.
or other doetoral)” or another “professional degree (e.g., M. D., J. D.).” Participants were
reeruited from the general community by placing advertisements in local newspapers,
some specifically targeting the elderly, and by word of mouth.

Design and Procedure
Interested persons contacted the primary researcher at the telephone numbers
provided. Informed consent was obtained over the telephone from each interested person
in accordanee with the UNLV OPRS guidelines for the proteetion o f human subjects.
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The researeher spoke direetly to the interested party, verified age, asked questions about
neurologieal disorders and medieations, and administered the Mental Status Questionaire
(MSQ; Kahn, Goldfarb, Pollaek, & Peek, 1960) to rule out obvious dementia. A eopy of
the MSQ is in Appendix II. Persons with an MSQ seore less than eight were told that
they did not qualify for this study. Additionally, any individual with a known
neurologieal disorder (i.e., Parkinson’s disease, Huntington’s disease, Alzheimer’s
disease, Piek’s disease, Creutzfeldt-Jaeobs disease, Vaseular dementia, stroke,
hydroeephalus, brain damage, delirium) were exeluded, as these ean signifieantly impaet
memory performanee. Furthermore, any individual taking a medieation for their memory
(i.e., Arieept, Exelon, Razadyne, Namenda) were exeluded from the study as these
medieations may eause individuals to perform better on the objeetive memory tests than
they would without medieation. O f the interested individuals, six were exeluded from the
study.
Before partieipating in the study, interested individuals were given the MSQ (Kahn et
ah, I960) via the telephone to rule out obvious dementia. Additionally, other pertinent
information (i.e., demographies, medieal history, medieations, psyehologieal history,
family history o f AD, questions pertaining to personal experienee with AD) was
obtained. If an individual met the inelusion eriteria explained above, an assessment was
seheduled to be eompleted at the UNLV eampus. Before testing eommeneed, the
researeh proeedures were explained to the partieipants and informed eonsent was
obtained in aeeordanee with the UNLV OPRS guidelines for the proteetion o f human
subjeets.
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Participants were evaluated by one o f three trained graduate students. To ensure that
the interviewers were highly qualified, each interviewer completed approximately five
hours o f training on administration of the instruments. Each interviewer observed a
testing session completed by the primary researcher before he/she conducted his/her own
testing session. After that, the primary researcher observed the interviewer. After
observations were completed, the interviewer was able to administer the evaluations
without the presence of the primary researcher.
Before completing any objective memory assessments, participants completed the
Memory Functioning Questionnaire (MFQ; Gilewski, Zelinski, & Schaie, 1990) so that
the participant’s perception of his/her memory was not affeeted by performanee on
objective memory tests. The tests were administered in the following order;
1. Mental Status Questionnaire via the telephone prior to testing session to
determine eligibility
2. Background Questionnaire via the telephone prior to testing session to determine
eligibility
3. Fear o f Alzheimer’s Disease Scale (FADS)
4. Memory Functioning Questionnaire (MFQ)
5. Logical Memory I
6. Digit Symbol - Coding
7. Digit Span
8. Abbreviated Boston Naming
9. Geriatric Depression Scale (GDS)
10. Logical Memory II
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11. California Verbal Learning Test - second edition (CVLT-II)
12. Knowledge about Alzheimer’s Disease (KADS)
13. State-Trait Anxiety Inventory - Form Y (STAI-Y)
After the interview was completed, scores from the individual objective memory
assessments were compared to normative data for individuals o f the same age. The
primary researcher was supervised by a licensed clinical psychologist when participants
obtained results outside the clinically normal range. The participant received notification
either in person or via telephone o f whether their test results were within a normal range
or if additional testing was recommended. If the results suggested that a follow-up was
necessary, the participant was given referrals to local neurologists, neuropsychologists,
and psychologists. Referral information was available upon request to all participants
regardless o f the outcome o f the assessment results. O f the 50 participants tested, three
individuals received negative feedback and were subsequently provided with referrals.

Measures
Demographic questionnaire
Participants were given the demographic questionnaire via the telephone prior to the
testing session to determine eligibility. Questions included information about age,
gender, marital status, ethnicity, education, medical history, current medications related
to memory decline, psychological history, and questions pertaining to experience with
AD. Participants were also asked about family history o f AD and/or other dementias.
When the participant reported a family history of AD or other dementias, he/she was
asked to reveal whether the family member diagnosed was a first or second degree
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relative or if he/she has multiple family members diagnosed. The partieipant was also
asked how emotionally elose he/she is to the family member(s) diagnosed. The
partieipant responded to this question on a 5-point Likert-type seale ranging from 1 (“Not
at all Close”) to 5 (“Extremely Close”). A copy o f the questionnaire is in Appendix III.
Assessment o f Fear o f Developing Alzheim er’s Disease
To examine levels o f anticipatory dementia, partieipants were given the Fear of
Alzheimer’s Disease Scale (FADS; French, 2005). The FADS is a 30-item self-report
measure used to assess anticipatory dementia aeross three different dimensions: older
adults’ basic and metamemory based fear o f developing AD (General Fear), physieal
symptoms that older adults experience due to tear of developing AD (Physical
Symptoms), and older adults’ eatastrophie thinking assoeiated with tear o f developing
AD (Catastrophie Attitude). Partieipants indicated their level o f agreement with the
statement using a 5-item Likert-type scale ranging from “never,” to “always.” The
minimum and maximum scores possible on the FADS are 0 and 120, respectively. A
copy of the FADS is in Appendix IV.
The FADS is a valid and reliable measure (Freneh, 2005). Internal eonsisteney was
measured in a sample o f l OI older adults ages 65 and older. Cronbaeh’s alpha for
“General Fear,” “Physical Symptoms,” and “Catastrophic Attitude” was found to be .94,
.85, and .80, respectively. Cronbaeh’s alpha for the entire instrument was .94. The
FADS was also found to have good construct reliability; scores on the FADS were
signifieantly eorrelated {r = .216, p < .05) with the total seore on the State-Trait Anxiety
Inventory - Form Y (French, 2005).
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Assessment o f Subjective Memory
The Memory Functioning Questionnaire (MFQ; Gilewski, Zelinski, & Schaie, 1990)
was used to assess the participants’ perceptions of their own memory. It is a 64-item
self-rated scale designed to examine a person’s metamemory, or perceived memory
functioning, across three different dimensions: general frequeney o f forgetting
(Frequeney o f Forgetting), the importanee o f what is forgotten (Seriousness of
Forgetting), and the amount of effort made, through mnemonics, to avoid failures
(Mnemonic Usage). Items are rated on a 7-point Likert seale ranging from I (frequently
a problem) to 7 (never a problem). Scores on the MFQ can range from 64 to 448, with a
lower seore indieating greater pereeived memory diffieulty.
Metamemory is assessed by asking the partieipant to eompare his/her memory now in
eomparison to how it was 1,5, 10, and 20 years ago and at the age o f 18. The lower the
score an individual receives on this scale, the more the participant perceives his or her
memory to be a problem. Therefore, higher scores on the MFQ factors are indicative o f a
low level o f memory eomplaints, infrequent use of mnemonies, and the pereeption that
memory is still intaet. A eopy o f the MFQ is in Appendix V.
The MFQ has been tested extensively on an older adult sample. Three-year test-retest
reliabilities o f the subscales ranged between .22 and .64. When looking at internal
eonsisteney in a sample o f 693 16 to 89 year olds, Cronbach’s alpha was found to be
between .82 and .93 (Gilewski & Zelinski, 1986).
Assessment o f Knowledge o f Alzheim er’s Disease
The Knowledge about Alzheimer’s Disease Seale (KADS; Carpenter, Balsis,
Otilingam, Hansen, & Gatz, 2006) was used to assess participants’ knowledge of
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Alzheimer’s Disease. The KADS is a 50-item questionnaire that assesses various aspeets
of knowledge about AD. Forty-nine o f the 50 questions are presented in a true-false
format. Question 50 asks partieipants to indieate how mueh knowledge they think they
have about AD on a 10-point Likert scale ranging from “I know nothing at all” to “I am
very knowledgeable.” A copy o f the scale is in Appendix VI. Seores on the KADS
range from 0 to 49, with a higher score indicating greater knowledge o f Alzheimer’s
disease. The KADS is eurrently in its pilot form. As sueh there are no data available to
demonstrate the psychometrie properties o f the questionnaire.
The KADS is the revised version o f the Alzheimer’s Disease Knowledge Test
(ADKT; Dieekmann, Zarit, Zarit, & Gatz, 1988). Seientifie knowledge about AD has
inereased dramatically since the development o f the ADKT. As such, the ADKT is an
outdated measure o f knowledge o f AD. Nonetheless, the ADKT is a psyehometrieally
sound measure as evidenced by eoefficient alphas ranging from .71 to .92. Construet
validity for the ADKT was also established (Dieekmann, Zarit, Zarit, & Gatz, 1988).
Assessment o f Objective Memory
Logical Memory I and II Subscales o f the Weehsler Memory Scale (WMS-III)
In Logical Memory I (LMI), the examiner reads two different stories (story A & B)
aloud to the partieipant. Story B is read twiee. After the stories are presented, the
partieipant is asked to retell eaeh o f the stories from memory. If the partieipant
inaceurately reealls or omits story and thematic units (e.g. units pertaining to main ideas
presented in the story), he/she receives 0 points. The reeall total seore for Logical
Memory I ean range between 0 and 75 points. A higher seore indieates better
performanee. The Psyehologieal Corporation (1997) found that the reliability coeffieient
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for individuals between 65 and 80 averaged .87. Test-retest reliability analysis revealed a
correlation coefficient of .77
In keeping with the administration guidelines, there was a 25-30 minute delay
between Logical Memory I and II. In the current study, participants completed DigitSymbol Coding, Digit Span, the Abbreviated Boston Naming, and the Geriatrie
Depression Seale (GDS) during the delay between Logieal Memory I and II. In Logieal
Memory II (LMII), the examiner asks the partieipant to retell both stories A and B from
the immediate condition. After the participant reports everything he/she remembers from
the two stories, the examiner asks yes/no questions about both stories. On Logical
Memory II, the partieipant ean reeeive a reeall total score anywhere between 0 and 50
with a greater seore again indieating better performanee. The Psyehologieal Corporation
(1997) performed a reliability analysis. The results of their analysis revealed a
correlation coeffieient o f .81 for individuals aged 65 to 89. The correlation coefficient
for test-retest reliability equaled .74. Both Logical Memory I and II showed good
eontent, eriterion, and eonstruet validity.
California Verbal Learning Test - Second Edition (CVLT-II)
The California Verbal Learning Test - Second Edition (CVLT-II; Delis, Kramer,
Kaplan, & Ober, 2000) measures memory for verbal information. The CVLT is
composed o f two word lists each comprising 16 words from four categories (Furniture,
Vegetables, Ways o f Traveling, and Animals). List A is the primary list and List B is the
interferenee list. The examiner presents List A five separate times. Each word is spoken
aloud by the administrator at a rate o f just over I per seeond. After eaeh list has been
presented, the partieipant freely recalls the items on List A. After the five immediate free
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recall trials o f List A, the examiner presents List B. The participant is asked to recall all
of the words from list B. This is followed by short delay free and cued recall trials o f List
A, 20-minute long delay free and eued reeall trials o f List A, a long delay recognition
trial o f List A, and a forced-choice reeognition task of List A. Scores on the CVLT-II
ean range between 0 and 80 for total recall, and 0 and 16 for both short and long delay
recall. The CVLT-II is a valid and reliable measure. Good internal consistency was
evidenced by a coefficient alpha .82 and a test-retest study yielded r = .82. Its validity is
based upon its relationship with the original CVLT, which was proven highly reliable and
valid. The correlation between the CVLT and the CVLT-II ranged from .63 to .86 (as
cited in Plake, Impara, & Spies, 2003, p. 177).
Digit Symbol - Coding Subscale o f the Weehsler Adult Intelligence Scale (WAIS-Ill)
In Digit Symbol-Coding, the participant is asked to copy hieroglyphic-like symbols
that are paired with numbers. Using the key provided, the partieipant finds the symbol
that corresponds with the number and draws it in the box below the number. The
partieipant has 120 seconds to fill in as many boxes as possible. The score is determined
by the number o f symbols correctly drawn. The maximum seore possible is 133.
Additionally, participants completed both the Incidental Learning - Pairing, and
Incidental Learning - Free recall subtests o f Digit Symbol - Coding. In the Incidental
Learning - Pairing subtest, the subject is asked to write down the symbol that
corresponds to eaeh number without looking at the symbol key. The maximum number
of points is 18. In the Incidental Learning - Free Reeall subtest, the subject is asked to
write down all o f the symbols that he/she can remember in any order. The participant can
obtain a maximum of 9 points on this subtest. The Psychological Corporation (1997)
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reports good psychometric properties for the WAIS-III. Specifically, it reports an
average reliability coefficient for the Digit Symbol - Coding subscale o f .87 in
individuals between the ages o f 65 and 89. Test-retest reliability for individuals between
55 and 74 was found to be .85 and .91 in individuals between 75 and 89. Digit SymbolCoding was also shown to be valid, as measured by construct, criterion, and content
validity (Psychological Corporation, 1997).
Digit Span Sub test o f the Weehsler Adult Intelligence Scale (WAIS-III)
There are two sections to the Digit Span subtest: Digit Span forward and Digit Span
backward. In both Digit Span forward and backward, the examiner reads a string of
numbers aloud at a rate o f one number per second. Each trial is comprised o f two sub
trials consisting of equal numbers in the string. The string o f numbers in each trial gets
progressively longer. The participant continues until he/she inaeeurately repeats both
sub-trials of the trial. In digit span forward, whieh is administered first, the partieipant
repeats the string o f numbers in the order in which they were read. In digit span
backward, the participant repeats the string o f numbers in the reverse order of what was
read. The maximum total score possible for both Digit Span forward and backward is 30
points. The Psyehologieal Corporation (1997) reports an average reliability eoeffieient of
.89 in individuals between the ages o f 65 and 89 for both digits forward and baekward.
Test-retest reliability analysis shows an average reliability o f .85 in individuals between
the ages of 55 and 75, and .69 in individuals between the ages o f 75 and 89. Digit Span
was also shown to be valid, as measured by construct, criterion, and content validity
(Psyehologieal Corporation, 1997).
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Abbreviated Boston Naming Test
The Boston Naming Test (BNT) is a naming vocabulary test (Kaplan, Goodglass,
Weintraub, 1978). The 15-item shortened version o f the BNT is from the Consortium to
Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological battery
(Morris, Mobs, Rogers, Fillenbaum, & Heyman, 1988). In the BNT, the examiner
presents 15 pictures from the original BNT to the participant. The pictures consist o f five
high frequency, five medium frequency, and five low frequency items. The participant
has 10 seconds to respond. In this version o f the BNT, no semantic or phonetic cues are
given. The participant’s score is based upon the number o f correct responses. The
maximum possible seore is 15 with higher seores indieating better performanee. Onemonth test-retest reliability was found to be .91 in patients and .77 in eontrols (WelshBohmer, & Mobs, 1997). Additionally, longitudinal studies have shown that the
abbreviated version o f the BNT has good validity (Morris, Edland, Clark, & Galasko,
1993).
Negative Mood
The Geriatrie Depression Seale (GDS; Yesavage et al., 1983) is a 30-item
questionnaire measuring depression in older adults using a yes/no format. Seores on the
GDS range from 0 to 30 with a higher score indicating more severe negative mood
symptoms. A copy o f the GDS is in Appendix VII. The initial validation study indicated
high internal consistency, with an alpha o f .94, and high convergent validity as indicated
by a eorrelation of .83 with the Hamilton Rating Seale for Depression (Yesavage et al.,
1983). One week test-retest reliability indieated a correlation o f 0.85 (Bums, Lawlor, &
Craig, 1999). Yesavage suggested using a score o f 11 or higher as an indication of
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depression. In fact, the sensitivity rate was 96% when using a cut-off score o f 10,
whereas the specificity rate was 96% (Olin, Schneider, Eaton, Zemansky, & Pollock,
1992). When a cut-off score o f 14 was evaluated, the sensitivity rate decreased to 80%
but the specificity rate increased to 100% (Bums, Lawlor, & Craig, 1999).
Anxiety
The State-Trait Anxiety Inventory - Form Y (STAI; Spielberger, Gorsuch, Lushene,
Vagg, & Jacobs, 1983) is designed to measure anxiety in “normal” individuals. There are
two 20-item sections. One section measures state anxiety (A-state), which is anxiety at a
specific moment. This can change easily as a result o f changes in the individual’s
environment. The other section measures trait anxiety (A-trait). Trait anxiety does not
change readily because it is considered the individual’s stable anxiety proneness. The
state anxiety scale is scored along a 4-point Likert scale ranging from “not at all” to “very
much so.” The trait anxiety scale is also scored along a 4-point Likert-type scale, only
this scale ranges from “almost never” to “almost always.” Scores on the STAI-Y overall
scale as well as both the state and trait anxiety subscales range from 40 to 160 and 20 to
80, respectively, with higher scores indicating more severe anxiety symptoms. In a study
by Spielberger and Krasner (1988) the STAI was found to have high internal consistency
(.86 to .95). The trait section was found to have good test-retest reliability o f .65 to .86.
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CHAPTER 4

RESULTS
Description o f the Measures
Before computing descriptive statistics, the data were screened for completeness,
accuracy in data entry, and outliers. Additionally, skewness and kurtosis were evaluated.
According to Curran, West, and Finch (1996), acceptable kurtosis and skew values lie
between ± 2 and ± 7, respectively. All variables evaluated (i.e, Fear o f Developing
Alzheimer’s Disease Scale - FADS, Memory Functioning Questionnaire - MFQ,
Knowledge about Alzheimer’s Disease Scale - KADS, composite score o f objective
memory, composite score o f cognitive measures. Geriatric Depression Scale - GDS, and
State-Trait Anxiety Inventory - Form Y - STAI-Y) approximated normality with regard
to kurtosis and skew. Maximum scores, means, and standard deviations for these
variables and their subscales are presented in Table 1. The total scores were used for the
FADS, MFQ, STAI-Y, and GDS unless otherwise specified. Descriptive information
about each variable will be provided later in this section.
Family history of AD was operationalized as the participants’ total number o f first
and second degree relatives diagnosed with the disease. Participants were asked to report
having a first-degree relative, a second-degree relative, or both with the disease. Twentyfour percent o f the participants reported a family history o f AD. O f these cases, 12% and
14% endorsed having a first-degree and second-degree relative diagnosed with the
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disease, respectively. Participants reported, on average, .42 family members diagnosed
with AD.
Description o f the FADS
The average score on the FADS was 25.44 (SD = 20.91) with a maximum score of
120, which indicates that, on average, participants in the current study endorsed “Rarely”
as the option for each statement. Specific rates of response for the FADS are presented in
Table 2. With regard to the three factors o f the FADS (General Fear, Physical
Symptoms, and Catastrophic Attitude), the maximum scores possible were 68, 32, and
20, respectively. The average score was 18.02 (SD = 14.30) on the General Fear factor,
indicating “Rare” responses on average, 1.42 (SD = 4.20) on the Physical Symptoms
factor, indicating “Never” responses on average, and 6.0 (SD = 4.69) on the Catastrophic
Attitude factor, indicating “Rare” responses on average. Most subjects ranked their fear
relatively low overall. A much lower percentage o f individuals endorsed the higher
symptomatology categories, suggesting some restriction in range.
Description o f the MFQ
On the MFQ, lower scores indicate greater perceived memory problems. Therefore,
higher scores on the MFQ factors are indicative of a low level o f memory complaints,
infrequent use o f mnemonics, and the perception that memory is still intact. The opposed
coding o f these variables is quite confusing with regard to data analysis and
interpretation. To facilitate easier data analysis and interpretation, the data was recoded
such that lower scores indicate a low level o f memory complaints and higher scores
indicate greater perceived memory problems.
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The average score on the MFQ was 284.14 (SD = 48.62) with a maximum score of
448, which equates to an average response of “Sometimes” / “Fair” / “Somewhat
Serious” / “ Same” depending upon the dimension being evaluated. This suggests that
participants neither perceived their memories as very good nor very poor.
Description o f the KADS
The maximum number of points possible on the KADS equals 49. The mean number
of points earned for the current study’s sample was 37.54 (SD = 3.80), which indicates
that the average percentage of items correctly answered on the KADS was 76.6%.
Assuming a normal distribution, the fact that participants responded much higher than
chance (i.e., 50%), it can be concluded that participants were well above average in terms
o f their knowledge o f Alzheimer’s disease.
Description o f Objective Memory Tests
With regard to the objective memory tests, two composite scores were created: (1) a
composite score of objective memory measures (i.e.. Logical Memory I, Logical Memory
II, CVLT-II recall total score, CVLT-II short-delay recall, CVLT-II long-delay recall),
and (2) a composite score o f cognitive measures (i.e.. Logical Memory I, Logical
Memory II, CVLT-11 recall total score, CVLT-11 short-delay recall, CVLT-II long-delay
recall. Digit Symbol, Digit Span, Boston Naming Test). The two composite scores were
created to address both memory specifically, and additional constructs (i.e., attention and
concentration, processing speed, confrontational naming) that may reflect memory
difficulties and a subsequent diagnosis o f dementia.
Both composite scores were calculated using averages o f z-scores for each measure.
The first composite score, objective memory, is comprised o f measures specifically used
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in evaluating short-term and long-term memory. The second composite score, cognitive
measures, encompasses cognitive measures often used in diagnosing dementia. These
measures not only include memory measures, but also measures o f attention, processing
speed, and confrontational naming. The objective memory composite score is the score
of vital importance to the hypotheses and subsequent analyses. However, the additional
measures in conjunction with the true memory measures are necessary for providing
adequate feedback about memory performance to each participant. To evaluate the
relationship between the two composite measures, a Pearson product-moment correlation
was calculated between the objective memory and cognitive measures constructs and was
found to be significant {r= .951, p < .001).
When assessing performance on the memory tests (i.e.. Logical Memory and CVLT
tests), we found that participants scored an average o f 120.92 points (SD = 28.76) out of
a possible 237, which suggested that participants’ memory in the current study was
within the average range when compared to individuals o f similar age, ethnicity, and
education level (note: CVLT norms are based solely on age). When assessing
performance on cognitive measures (i.e., Logical Memory, CVLT, Digit Symbol, Digit
Span, and BNT), it was found that participants scored an average o f 243.48 points (SD =
41.62) out o f a possible 442, suggesting that, when taking all cognitive measures into
account, participants again scored in the average range with regard to memory, attention
and concentration, processing speed, and confrontational naming when compared to
individuals o f similar age, ethnicity, and education level (note: CVLT and BNT norms
are based solely on age).
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Description o f the GDS
Participants can obtain a maximum o f 30 point on the Geriatric Depression Scale
(GDS). Researchers suggest that a score o f 0-9 indicates “normal” levels o f negative
mood, 10-19 indicates “mild” depression, and 20-30 reveals “severe” depression
(Yesavage et al., 1983). In the current study, participants received an average of 4.6
points (SD = 4.73), indicating “normal” levels of negative mood in general.
Description o f the STAI-Y
On the STAI-Y, participants can receive a maximum o f 160 points. Eighty of those
points can be obtained on both the State and Trait Anxiety subscales. In the current
study, participants received an average o f 29.34 (SD = 10.20) and 31.28 (SD = 8.78)
points on the state and trait anxiety subscales, respectively. On the STAI-Y, as a whole,
participants scored an average o f 60.62 points (SD = 17.23). Results indicate that
participants, on average, were experiencing relatively low levels o f anxiety at the time o f
testing.

Hypothesis Testing
The Relationship between Fear o f Developing AD and Subjective Memory Complaints,
Family History o f AD, Knowledge o f AD, and Objective Memory
The correlations among family history, FADS, MFQ, KADS, GDS, STAI, and the
objective memory and cognitive measures composite scores are presented in Table 3.
A central hypothesis to the current research was that fear o f developing AD would be
correlated with subjective memory, family history, and knowledge o f AD, but not to
objective memory. To test this hypothesis, Pearson product-moment correlations
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between the MFQ, family history, KADS, objective memory composite score, cognitive
measures composite score, and the FADS were computed. As hypothesized, subjective
memory was positively associated with the FADS (r = .33, p < .05). Contrary to the
hypothesis, however, significant correlations were not observed between family history
of AD and the FADS (r = .10, p > .05), nor the KADS and the FADS (r = -.10, p > .05).
Furthermore, emotional closeness with an afflicted family member, as experienced by the
participant, was also not significantly correlated with the FADS (r = .511,/» > .05).
Lastly, as hypothesized, the FADS was not correlated with the objective memory (r = .13, p > .05) or cognitive measure (r = -.22,/» > .05) composite scores.
Predictors o f Fear o f Developing Alzheim er’s Disease
Flierarchical regression was conducted to determine the degree to which subjective
memory (MFQ), family history of AD (number o f family members endorsed by each
participant), knowledge o f AD (KADS), and objective memory (composite score of
objective memory tests) predicted adults’ fear of developing AD.
Variables were entered into the hierarchical regression analysis in sequential blocks:
(1) MFQ, (2) family history, (3) KADS, and (4) the objective memory composite score.
The order in which the variables were entered into the equation was based upon the
strength o f the correlations found previously in French (2005) such that the variable most
strongly correlated with the FADS (i.e., MFQ) was entered into the equation first. French
(2005) found that the MFQ was most strongly positively correlated with the FADS (r =
.32, p < .001) followed by family history {r = .26, p < .01). In this study, it was also
found that objective memory was not significantly correlated with the FADS {r - -.09, p
> .05). For this reason and for the reason that objective memory was again expected to
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not predict fear, objective memory was entered into the equation last. Little is known
about the relationship between knowledge o f AD and fear o f AD. Thus, the KADS was
entered into the equation after the MFQ and family history, but before the objective
memory composite score.
Table 3 displays the correlations between the variables. Table 4 displays the
unstandardized regression coefficients (B) and standard errors (SE B), the standardized
regression coefficients (B), adjusted

, and Rechange for each step in the regression.

After step 1, with subjective memory in the equation, R^ = A \ ,F { \ , 48) = 6.03,/» <
.05. Addition o f family history o f AD, knowledge of AD, and objective memory did not
reliably improve R^ at steps 2, 3, or 4 o f the regression analysis. After step 4, with all
independent variables in the equation, R^ = .13, F{4, 45) = 1.12, p > .05. Results from the
hierarchical regression analysis revealed that neither family history of AD, knowledge of
AD, nor objective memory improved prediction o f older adults’ fear o f developing AD
beyond that afforded by subjective memory.
The Relationship between Knowledge o f AD and Levels ofA nxiety
A Pearson product-moment correlation was computed between the KADS and the
STAI-Y to examine the hypothesis that a positive association would exist between the
variables. Results of the analysis revealed no significant relationship (r = -.16,/» > .05).
The Relationship between Subjective Memory Complaints and Objective Memory
To test the hypothesis that there would be no significant relationship between
subjective memory complaints and objective memory, a Pearson product-moment
correlation was calculated between the MFQ and the objective memory and cognitive
measures composite scores. Data analysis revealed that, in fact, no significant
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relationship existed between the MFQ and either of the composite scores (objective
memory; r = 2 6 , p > .05; cognitive measures: r = 2 6 ,p > .05).
The Relationship between Fear o f Developing Alzheimer's Disease and
Subjective Memory Complaints after Controlling fo r Negative Mood
Significant correlations were found between the FADS and the MFQ {r= .33,p <
.05) and the FADS and the GDS (r = .42, p < .01). No significant correlation was
observed between the MFQ and the GDS (r= .16, p > .05). As proposed, a partial
correlation was conducted to examine the relationship between the FADS and the MFQ
after removing the effects of the GDS to ensure that negative mood was not affecting the
relationship between subjective memory and fear of developing AD. The analysis
revealed a p r = .30, p < .05. Results of this analysis support the hypothesis that the
relationship between fear of developing AD and subjective memory would still be
significant even after controlling for the effects of negative mood. This finding implies
that the relationship between subjective memory and fear o f developing AD is
sufficiently strong and independent o f negative mood.
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CHAPTER 5

DISCUSSION
Relationships with and Predictors o f Fear o f Developing Alzheim er’s Disease
Fear o f Developing AD and Subjective Memory Complaints
In the current study it was hypothesized that subjective memory complaints would be
positively correlated with and significantly predictive o f fear o f developing AD. These
hypotheses were substantiated, confirming prior research findings that a significant
relationship exists between subjective memory and fear o f developing AD (Cutler &
Hodgson, 1996; Cutler & Hodgson, 2001; French, 2005; Hodgson & Cutler, 2003,
Werner, 2002). The fact that all published studies to date, including the current study,
have found a significant relationship between subjective memory and fear o f developing
AD, substantiates the notion that older adults are more likely to fear developing AD if
they perceive their memory as poor.
Fear o f Developing AD and Family History o f AD
Based on the study by French (2005), it was also hypothesized that family history of
AD would be significantly correlated with and predictive o f fear o f developing the
disease. In contrast to French (2005), the current study found a relationship in the
predicted direction, albeit non-significant. The results, therefore, failed to confirm the
proposed hypotheses, signifying that individuals with a family history o f AD are no more
afraid o f developing the disease than individuals without a family history.
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The reason for the discrepancy between studies is somewhat perplexing considering
the similarities in methodology. Both studies operationalized family history o f AD in the
same way: an individual was considered to have a family history o f AD if either a first or
second degree family member was diagnosed with AD. Additionally, both studies used
the FADS to assess older adults’ fear o f developing AD. The fact that the variables are
identical leads the researcher to conjecture that the inconsistency in the results may be
due to the differences in the samples studied.
Participants in the current study were recruited differently than those in the previous
study because o f more stringent rules implemented by the UNLV Institutional Review
Board. In French’s (2005) study, individuals were recruited from a wide variety of
locations including retirement homes, senior centers, adult living complexes, and local
neurology clinics. Additionally, many of the participants were tested in these facilities
because o f their inability to travel to UNLV for testing. In fact, the majority o f testing
appointments occurred in the community as opposed to on the UNLV campus. In the
current study, very few subjects were recruited from senior facilities; the vast majority of
participants were recruited from the community via newspaper ads and word o f mouth.
Moreover, all of the participants lived independently and were able to attend the testing
session on the UNLV campus, suggesting, perhaps, a higher level o f overall ability.
In addition to finding disparities between the two studies with regard to both testing
locations and residence types, differences can also been found in demographic variables.
When analyzing both the French (2005) and current studies, differences in education,
(%^(7, 50) = 41.72,/» < .01) and ethnicity (%^(5, 50) = 11.32,/» < .05) emerged. With
regard to education, participants in the current study had significantly higher levels of
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education; participants in the current study had completed, on average, a Bachelor’s
degree, whereas participants in French’s 2005 study had completed, on average, only
some college without receiving even an Associate’s or technical degree. Furthermore,
only 8% o f participants in the current study were ethnic minorities compared to 20% in
the French (2005) study. Please refer to Table 5 for a comparison o f demographic
variables between French’s 2005 study and the current study.
Another possibility for the discrepancy in results between studies rests in the
differences in sample sizes. French (2005) found a moderate correlation (r = 2 6 , p < .01)
between family history and the FADS, whereas a much smaller relation was found in the
current study (r = . 10,/> > .05). Although not significant, the relation between farnily
history and the FADS in the current study is in a similar direction as that in the study by
French (2005). It is possible that a larger sample size would allow for greater variability
in both family history and the FADS, possibly yielding a stronger and more significant
relation. This conjecture is further supported when examining effect sizes.
In the current study the sample size was sufficient enough to replicate some o f the
more robust effects from the French (2005) study. Specifically, in both studies,
subjective memory was associated with and predictive of fear o f developing Alzheimer’s
disease. In addition, given the smaller sample size in the current study (N = 51) versus
that o f French (2005; N = 101), the robustness o f the effect o f one’s appraisal on one’s
own memory in the prediction o f fear o f developing AD, is further exemplified. A
smaller sample size than that in French’s 2005 study did, however, seem to contribute to
the lack of replication o f results that were less robust. Specifically, power analyses
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indicated that many more participants would be needed to replicate the prior findings of a
significant relation between family history of AD and one’s fear o f developing AD.
Taken together, differences in demographic variables as well as a possibly
insufficient sample size may be contributing to the lack of replication o f the relationship
between family history and fear o f developing AD. Future investigation would benefit
from sampling a larger and more diverse, both ethnically and educationally, population.
Specifically, a sample of twice to three times that in the current study as well as a
population with more lower end variability with regard to education as well as a greater
representation o f minorities might increase the likelihood of replicating the less robust
findings o f French (2005).
Fear o f Developing AD and Knowledge o f AD
Few studies have addressed the relationship between knowledge o f AD and anxiety
regarding development of the disease. O f these studies, one found no relationship
between knowledge o f AD and fear (Commissaris et al., 1994), another found that
increased knowledge o f AD decreased fear o f AD (Commissaris et al., 1995), and the last
found that, as knowledge o f AD increased so did fear o f developing the disease (LaForce
& McLean, 2005).
Based upon the previous studies and the Medical Students’ Disease construet, it was
hypothesized that as knowledge o f AD increased so would fear o f developing the disease.
Unfortunately only a small, non-significant correlation {r = -AO, p >.05) was found
between knowledge o f AD and fear o f developing AD. In addition, the subsequent
regression analysis o f factors contributing to fear o f developing AD, knowledge, as an
individual predictor, did not contribute significantly to the prediction o f fear o f
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developing AD {fs = -.056, -.045; p > .05). O f note, however, is the fact that the
measurement of AD was based on the KADS. And, although the parent measure of the
KADS (i.e., ADKT) was a psychometrically sound instrument, the KADS is currently in
its pilot form, and thus, may not have the same psychometric properties as the original
questionnaire, thereby possibly affecting the results of the study.
It is difficult to interpret this finding. There are relatively few studies comparing
knowledge of AD and fear of developing AD and of those extant studies, none is in
agreement. Results from this study, however, are consistent with Commissaris and
colleagues’ (1994) results. Future research using comparable methodology will aid in
determining whether or not “a lot of knowledge [is] a bad thing...” (Chapman & Bilton,
2004, p. 369).
Fear o f Developing AD and Objective Memory
Whereas it was hypothesized that subjective memory, family history o f AD, and
knowledge o f AD would be both be positively correlated with and significant predictors
o f fear of developing AD, objective memory was thought to not be associated with or
predictive of this fear, which is precisely what was found in the current study. This result
suggests that, regardless o f an individual’s actual memory performance on standardized
tests o f memory, he/she will not be afraid o f developing AD. Individuals with impaired
memory will be no more afraid of developing AD than individuals with a good/”normal”
memory. Only one other study has directly examined this relationship (French, 2005).
The current finding is important because it replicates the results found in this previous
study.
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Previous research has shown that individuals with actual memory impairments do not
believe, or at least they do not admit, that they have a problem (Bouchard & Rossor,
1999). Additionally, both the current study and previous studies have revealed that
individuals are afraid o f developing the disease if they believe their memory is poor.
Therefore, the current study lends support to the notion that memory-impaired individuals
are not afraid of developing AD because they do not believe they have a memory
problem.

Relationship between Knowledge of AD and Levels o f Anxiety
Only two studies thus far have addressed the relationship between knowledge of AD
and anxiety (Graham et al., 1997a; Proctor et al., 2002). These studies found that as
knowledge of dementia increased, so did anxiety. Based upon the previous studies, the
Medical Student Disease concept, and the hypothesis that knowledge o f AD would be
associated with fear o f developing AD (as discussed in the introduction), it was also
conjectured that knowledge of AD would be associated with anxiety. This hypothesis
was not substantiated.
One reason for the disparity in results may be a reflection o f the population being
examined. Both Graham et al. (1997a) and Proctor et al. (2002) tested the relationship
between knowledge o f AD and anxiety using caregivers o f dementia patients. The current
study utilizes older adults from the community. In fact, only 10% o f the participants
were caregivers to patients with AD at the time o f testing. Being a caregiver can
dramatically increase not only knowledge of AD, but also anxiety levels (Mahoney,
Regan, Katona, & Livingston, 2005; Schulz, O ’Brien, & Bookwala, 1995). Therefore, if
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the current study utilized caregivers as the previous studies did, the hypothesis may have
heen substantiated.

Relationship between Subjective and Objective Memory
In the current study it was hypothesized that there would he no relationship between
subjective and objective memory. This hypothesis was substantiated suggesting that an
individual’s perception of his/her memory does not accurately reflect the individual’s
actual memory. Previous research investigating the relationship between subjective and
objective memory has heen mixed. Some research has found a positive relationship
between the two variables (Gagnon et al., 1994; Jonker et al., 1995; Jonker et al., 1996;
Johansson et al., 1997; McPherson et al., 1995; Wang et al., 2000; Zelinski et al., 1980).
Most research, however, has found either a weak/modest relationship (Bolla et al., 1991 ;
Hertzog et al., 2000; Schmidt et al., 2001; Zelinski et al., 2001) or no relationship
(French, 2005; Kahn et al., 1975; Riedel-Heller et al., 1999; Schofield et al., 1997). The
current study provides additional information in support o f the belief that there is no
significant relationship between subjective and objective memory. And, because many of
the methodological problems (i.e. utilizing single-item questionnaires or measures
without good psychometric properties to address subjective memory) plaguing previous
studies were corrected in the current study, it gives even further credibility to this notion.
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The Relationship between Fear of Developing Alzheimer’s Disease and
Subjective Memory Complaints after Controlling for Negative Mood
To ensure that the relationship between subjective memory and fear o f developing
AD was not due to negative mood in the current study, the effects o f negative mood were
statistically removed from the correlation between the subjective memory measure and
the FADS. The correlation between subjective memory and fear o f developing AD
remained significant even after removing the effects o f negative mood suggesting that
negative mood does not impact an individual’s perception o f his/her memory.
Individuals who believe their memory is poor are afraid o f developing AD regardless of
whether or not their mood is negative.

Limitations and Future Research
The current study was able to improve upon many o f the previous studies by
addressing several o f their limitations. For example, in the current study we (1) used a
psychometrically sound instrument for measuring fear o f developing AD, (2) used a 49
item questionnaire to assess knowledge o f AD rather than asking just a few questions, (3)
excluded individuals using cognitive enhancing medication, and (4) utilized communitydwelling individuals ages 65 and older who are at particular risk for developing AD. Yet,
even though great effort was made in addressing limitations from previous studies, not all
limitations could be foreseen.
The generalizability o f the findings of the current study to the broader population may
be somewhat limited due to the nature of the participants. First, in the current study, the
researchers were able to obtain a fairly representative sample o f community-dwelling
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Caucasian individuals. However, older adults from ethnic minority groups were
underrepresented. Secondly, individuals were recruited mainly from the general
community; only a few participants were recruited from senior institutions. Thus, caution
should be taken in generalizing results o f this study to older adults from underrepresented
ethnic groups and living facilities other than those in the general community.
Secondly, participants included in the study were pre-screened for gross memory
impairment and neurological disorders. Therefore, results o f the study can only be
generalized to individuals with no known neurological impairments and those without
obvious dementia.
Other major limitations o f the current study pertain to family history o f AD. Only
24% o f individuals reported a family history o f AD. This number is reduced to 12%
when looking specifically at first-degree relatives with the disease. As discussed
previously, having a larger sample size in general and a larger sample size o f individuals
with a family history of AD more specifically, may yield stronger results than the ones
found in the current study. Additionally, a larger sample o f this nature would also allow
researchers to make valid comparisons between individuals with and without a family
history of AD.
Measuring family history of AD in older adults is difficult. The current study used
self-report data from participants. This is problematic in that individuals must rely upon
retrospective information o f family members that may or may not be accurate. This is in
part due to the fact that Alzheimer’s disease as a labeled medical condition did not gain
wide-spread use until approximately 25-30 years ago when the National Institute of
Health / National Institute on Aging was established. And, it was not even until several
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years after the inception o f the NIA that researchers began receiving funding for
exploration of AD and related dementias (Kalamazoo Center for Medical Studies, n.d.).
Therefore, many of the participants may not have factual information about their
relatives’ diagnoses as many o f the inflicted relatives lived prior to the AD social
movement. Having information from both the participant and an additional, reliable
informant could confirm that a family history o f AD actually existed. Another option
would be to use medical records o f diagnosed family members to confirm a diagnosis o f
AD.
Another limitation lies in the measure being used to address knowledge o f AD. The
Knowledge about Alzheimer’s Disease Scale (KADS; Carpenter et al., 2006) employed
in the dissertation is in its pilot form. The psychometric properties o f this questionnaire
have yet to he determined. Furthermore, the True/False response choices do not allow for
significant variation in responses. And, most individuals, although reporting that they do
not know much about AD, actually performed fairly well on the test causing a ceiling
effect. Future research using the KADS in its psychometrically sound form will aid in
determining the accuracy of the current study’s results.
Finally, subjective memory accounts for only 9.3% o f the variance in fear o f
developing AD. Future research might explore what other variables account for the
remaining variance. Some of these potential variables worth exploring include additional
risk factors such as head injury and vascular health, financial constraints, relationship
with potential caregivers, and spiritual beliefs.
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Conclusion
In the current study we found that: (1) in-line with existing studies, subjective
memory was positively associated with fear of developing AD, (2) family history,
knowledge o f AD, and objective memory were not significantly correlated with fear of
developing AD, (3) subjective memory was the only significant predictor o f fear o f
developing AD; neither family history, knowledge o f AD, nor objective memory
predicted fear o f developing the disease, (4) knowledge o f AD was not associated with
anxiety, (5) there was no significant relationship between subjective and objective
memory, and (6) the relationship between subjective memory and fear o f developing AD
was still significant after controlling for participants’ negative mood.
From a research perspective, the results o f the current study are novel and important
for several reasons. To date, the few published studies examining peoples’ fear of
developing AD have focused on correlating fear with only two main variables: anxiety or
subjective memory. The current study not only replicated these published studies in
finding positive associations between fear o f developing AD and anxiety or subjective
memory but also extended these previous results by including additional relevant
variables such as subjective and objective memory function, family history, and
knowledge o f AD. Even though these additional variables failed to exhibit significant
correlations with fear o f developing AD, we have a better understanding o f how they
relate to such fear.
From a clinical standpoint, these findings will aid clinicians in determining what
aspects are possibly contributing to their clients’ fears o f developing AD. In addition to
therapy, psychoeducation about the relationship between fear o f developing AD and

61

subjective memory complaints, family history, knowledge o f AD, and objective memory
may prove beneficial to clients in that it may help assuage their fears o f developing AD.
In conclusion, Alzheimer’s disease is becoming increasingly prevalent. Yet, older
adults’ fear o f developing AD has received little attention in the literature. Part o f this
may be due to the fact that, until recently, there were no psychometrically sound
instruments to measure this tear. The development o f the Fear o f Alzheim er’s Disease
Scale (FADS; French, 2005) provides researchers the opportunity to explore older adults’
fear o f developing AD and along with this instrument, the variables possibly affecting
fear of developing this degenerative disease.
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Table 1
Maximum Scores, Means and Standard Deviations o f Measures and their Subscales

(A-JO)
Measure
Fear o f Alzheimer’s Disease Scale (FADS)
General Fear
Physical Symptoms
Catastrophic Attitude

Max
120
68
32
20

Mean
25.44
18.02
1.42
6.00

SD
20.91
14.30
4.20
4.69

Memory Functioning Questionnaire (MFQ)
General Frequency o f Forgetting
Seriousness o f Forgetting
Retrospective Functioning
Mnemonic Usage

448
224
126
35
56

284.14
164.00
8236
16.06
21.72

48.62
2638
23.15
4.92
10.52

49
10

37.54
5.38

3.80
1.75

Composite Score of Objective Memory
Logical Memory I Recall Total Score
Logical Memory I Scaled Score
Logical Memory II Recall Total Score
Logical Memory II Scaled Score
CVLT-II Recall Total Score
CVLT-II Recall T-Score
CVLT-II Short Delay Recall
CVLT-II Long Delay Recall

237
75

120.92
38.82
11.64
23T8
12.04
47.80
57.64
9.76
10.80

2836
10.34
3.04
9.01
3.16
10.14
10.13
3.11
3.31

Composite Score o f Cognitive Measures
Digit Symbol Total Score
Digit Symbol Scale Score
Incidental Learning Pairing
Incidental Learning Free Recall
Digit Span Total Score
Digit Span Scaled Score
Boston Naming Test Total Score

442
133

15

243.48
63.20
12.62
9.94
6.72
18.70
12.88
14.72

41.62
13.52
2.76
4.27
1.40
3.75
2.96
0.57

30

4.60

4.73

Knowledge about Alzheimer's Disease Scale (KADS)
Perceived Knowledge o f AD

50
80
16
16

18
9
30

Geriatric Depression Scale (GDS)

State-Trait Anxiety Inventory - Form Y (STAI)
17.23
160
60.62
State Anxiety Subscale
10.20
2934
80
Trait Anxiety Subscale
80
31.28
8.78
Note. The Composite Score of Cognitive Measures includes both the measures listed and
the measures contained in the Composite Score o f Objective Memory.
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Table 2
Percentage o f responses fo r the Fear o f Alzheim er’s Disease Scale (N = 50)
Item
Never
Rarely
________________________________________________________________________

Som e
often
A lw ays
times________________ 2__

I am afraid o f getting Alzheimer’s disease.

10

34

40

14

2

W hen I forget something, I am apt to think that I
am developing Alzheim er’s disease.

24

42

24

8

2

My heart races or palpitates when I think about
getting Alzheim er’s disease.

82

14

I cannot sleep because I’m worrying about
developing Alzheim er’s disease.

92

I would rather die than develop Alzheimer’s
disease.

52

16

16

1 am afraid o f developing Alzheimer’s disease
because o f the burden 1 would be for my family.

28

30

26

When 1 think about the possibility o f developing
Alzheim er’s disease, 1 become nervous or
anxious.

60

26

10

The more 1 learn about Alzheimer’s disease, the
more fearful 1 become o f getting it.

42

28

22

When 1 misplace things, 1 sometimes think that 1
may have Alzheim er’s disease.

36

34

24

1 feel hot and even sweat when 1 think about
developing Alzheim er’s disease.

86

10

2

Developing Alzheimer’s disease would be the
worst thing to happen to me.

44

20

22

1 fear not recognizing family members.

48

30

8

12

1 think that 1 will probably get Alzheimer’s
disease and it frightens me.

58

20

16

8

Even though my memory is good, 1 am still
afraid of developing Alzheimer’s disease.

26

42

22

10

My hands become clammy when 1 think about
getting Alzheimer’s disease.

90

10

Thinking about Alzheim er’s disease makes me
feel fatigued.

65

Rarely

Some
times

36

26

18

48

36

14

56

22

12

40

34

20

I’m afraid o f losing my memories.

28

22

34

The older 1 get, the more fearful 1 become that 1
may develop Alzheimer’s disease.

32

34

24

1 believe that Alzheimer’s disease is one o f the
worst diseases a person could develop.

24

22

28

58

18

16

28

30

The worse my memory becomes, the more 1 fear
that 1 may have Alzheimer’s disease.

36

1 sometimes think that 1 am developing
Alzheimer’s disease.

58

Never

Item

I often have difficulty concentrating because
I’m worrying about developing Alzheimer’s
disease.
Developing Alzheimer’s disease frightens me
because 1 would eventually lose all o f my
independence.
Now that Alzheimer’s disease is becoming more
public with the diagnosis o f popular T.V.,
movie, and political figures (e.g., Charlton
Heston, Ronald Reagan), 1 am becoming more
afraid that 1 may develop it.

86

My appetite decreases when 1 think about
developing Alzheimer’s disease.

98

1 worry about developing Alzheim er’s disease
more than 1 worry about developing other
diseases.
I’m afraid o f getting Alzheimer’s disease
because 1 would have to rely on someone else to
take care of me.

66

Always

90

1 feel shaky when 1 think about getting
Alzheimer’s disease.

1 would rather have a painful physical illness
(e.g., cancer, AIDS) than develop Alzheimer’s
disease.
When 1 hear about others with Alzheimer’s
disease, 1 become fearful that 1 will get it as
well.

Often

12

12

14

12

16

16

10

38

10

10

26

10

Table 3
Correlations among Measures

Family
History
FADS
MFQ
KADS

FADS

MFQ

KADS

.10

.17

.24

33*

-.10
-.17

GDS

.01

.42**

.44**

-.13

-3 2

.16

.41**

-3 6

-3 6

-3 8 *

.71***

Objective
Memory

Cognitive
Measures

-.01

-3 9 *

STAI

Objective
Memory

.22

-.18

GDS

STAI

33*

39*

-.07

-.12

-.19

-3 2

gg***

Note. FADS = Fear o f Alzheimer’s Disease Scale; MFQ = Memory Functioning Questionnaire;

GDS = Geriatric Depression Scale; STAI = State-Trait Anxiety Inventory; Objective Memory is
the composite score o f the memory measures; Cognitive Measures is the composite score o f the
Objective Memory tests plus the additional cognitive measures.
* p < . 0 5 . **p< .01. * * V < .001.
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Table 4
Summary o f Hierarchical Regression Analysis fo r Variables Predicting Fear o f
Developing Alzheim er’s Disease (N = 50)
Variable

B

SEE

B

Step 1
MFQ

.14

.06

.33*

Step 2
MFQ
Family History

.14
.96

.06
2.88

.33*
.05

Step 3
MFQ
Family History
KADS

.14
1.28
-.31

.06
3.02
.81

.31*
.06
-.06

Step 4
MFQ
Family History
KADS
Objective Memory

.13
1.24
-.25
-.19

.06
3.06
.85
.76

.31*
.06
-.05
-.04

Adjusted

Change

.09

.11

.08

.00

.06

.00

.06

.02

Note. MFQ = Memory Functioning Questionnaire; Family History is the number of
relatives with Alzheimer’s disease; KADS = Knowledge About Alzheim er’s Disease;
Objective Memory is the composite score of the memory measures.
*p < .05.
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Table 5
Demographic information fo r participants in the French (2005) study (N = 101) and the
current study
Demographic Variable

French (2005)
(% o f participants)

Current Study
(% o f participants)

Age

M=73.45; SD=6.86

M=72.24; SD=5.37

Gender
Male
Female

35
65

48

Marital Status
Single
Married
Divorced
Widowed

4
44
22
30

10
52
22
16

Ethnicity
African American
Asian
Caucasian
Latino/Hispanic
Native American
Pacific Islander/Filipino
Other

13
1
80
5
0
0
1

2
,4
92
0
2
0
0

Religious Affiliation
Buddhist
Catholic
Jewish
Muslim
Protestant
Latter Day Saints
No Affiliation
Other

0
22
11
0
39
2
23
3

2
10
18
0
26
2
40
2

Education Level
Some high school or less
Graduated Fligh School (or GED)
Technical or Associate’s degree
Some College
Bachelor’s degree
Some graduate school
M aster’s degree
PhD, JD, or MD Degree

11
42
8
1
22
0
12
4

4
14
4
26
20
2
14
16
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APPENDIX II
MENTAL STATUS QUESTIONNAIRE (MSQ)

QUESTION

RESPONSE

RIGHT
(1)

1. What is the name o f this
place?
2. Where is it located
(address)?
3. What is today’s date?
4. What is the month now?
5. What is the year?

6. Plow old are you?
7. When were you bom
(month)?
8. When were you bom
(year)?
9. Who is the president of
the U.S.?
10. Who was the president
before him?

TOTAL SCORE
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WRONG
(0)

APPENDIX III
PERSONAL BACKGROUND INFORMATION
Name:
Address:
C ity:________________

State:_____________

Home Phone:

Zip Code:

Work Phone:

Can we leave a message at these numbers? □ Yes □ No
A g e:__________ Date o f B irth:____________
Gender: □ Male □ Female
Marital Status: □ Single □ Married □ Divorced OW idowed
Ethnicity (Please check only one):
□ African American □ Asian
□ Latino/Hispanic

□ Native American

□ Caucasian □ Pacific Islander/Filipino

□ O ther:__________________________
Were you bom in the United States?

□ No

□ Yes

If NO, how old were you when you moved to the U. S .? _______
Do you speak English fluently?

□ No □ Yes

Religious Affiliation (Please check only one):
□ Buddhist

□ Catholic

□ Protestant

□ Latter Day Saints O O th er:_________________

What
□
□
□
□
□
□
□
□
□
□

□ Jewish

was your highest level of education?
Some high school or less
Graduated high school (or GED)
Some technical or associate coursework
Technical or associate’s degree
Some college
Bachelor’s degree
Some graduate school
M aster’s degree
Doctoral (Ph.D., other doctoral) degree
Professional degree (e.g., M.D., J.D.)
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□ Muslim

What is/was your primary occupation?__________________________
Would you like to participate in future research if available? □ Yes □ No
If YES, can we contact you by phone? □ Yes □ No
If YES, can we contact you by mail? □ Yes □ No
_________________________ MEDICAL HISTORY____________
Do you have any current medical problems? □ Yes □ No
If YES, please list what medical problems you currently have:
1. Medical Diagnosis/Problem:___________________________
2. Medical Diagnosis/Problem:___________________________
3. Medical Diagnosis/Problem:___________________________
Have you ever had open-heart surgery? □ Yes □ No
Have you ever been diagnosed with or had any o f the following:
□ Parkinson’s Disease

□ Huntington’s Disease

□ Alzheimer’s Disease

□ Pick’s Disease

□ Creutzfeldt-Jakob Disease

□ Vascular Dementia

□ Stroke

□ Hydrocephalus

□ Brain damage

□ Delirium

□ Endocrine Disorder (please list):____________________
□ Major organ system impairment (examples: heart, lung, liver,
kidney). Please lis t:___________________________________
Are you taking any o f the following medications:
□ Aricept

□ Exelon

□ Reminyl

□Razadyne

□ Cognex

□ Namenda

Do you have any problems walking? □ Yes □ No
PSYCHIATRIC HISTORY
Have you ever been diagnosed with or had any o f the following:
□ Major Depression

□ Schizophrenia

□ Post-Traumatic Stress Disorder (PTSD)
□ Anxiety Disorder (please list type(s)):_____________________
□ Alcohol or substance abuse or dependence
Other:
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Do you drink alcohol? □ Yes □ No
If YES, please complete the following:
I . How frequently do you drink?_____
2. When you drink, what do you usually drink?_
Do you use any recreational drugs? □ Yes □ No
If YES, please complete the following:
1. How frequently do you use recreational drugs?_
3. What recreational drugs do you use?
FAMILY HISTORY
Have any o f your biological family members ever been diagnosed with Alzheimer’s
Disease? □ Yes DNo
□ First degree relative (Mother, Father, Sibling, Child)
Has more than one first degree relative been diagnosed with Alzheimer’s
Disease? □ Yes DNo
If YES, how many o f your first degree relatives have been
diagnosed?___________
How emotionally close are you to your first degree relative #1?
Not at all Close
1
2

Somewhat Close
3

4

Extremely Close
5

How emotionally close are you to your first degree relative #21
Not at all Close
1
2

Somewhat Close
3

4

Extremely Close
5

How emotionally close are you to your first degree relative #3?
Not at all Close
1
2

Somewhat Close
3

4

Extremely Close
5

How emotionally close are you to your first degree relative #4?
Not at all Close
Somewhat Close
Extremely Close
1
2
3
4
5
□ Second degree relative (Grandfather, Grandmother, Aunt, Uncle)
Has more than one second degree relative been diagnosed with
Alzheimer’s Disease? □ Yes DNo
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If YES, how many o f your second degree relatives have been
diagnosed?__________
How emotionally close are you to your second degree relative #1?
Not at all Close
1

Somewhat Close
2
3

4

Extremely Close
5

How emotionally close are you to your second degree relative #2?
Not at all Close
1

Somewhat Close
2
3

4

Extremely Close
5

How emotionally close are you to your second degree relative #3?
Not at all Close
1

2

Somewhat Close
3

4

Extremely Close
5

How emotionally close are you to your second degree relative #4?
Not at all Close
1

2

Somewhat Close
3

4

Extremely Close
5

QUESTIONS PERTAINING TO ALZHEIM ER’S DISEASE
Have you heard of Alzheimer’s disease? □ No
□ Yes
Are you currently the main family caregiver for someone with Alzheim er’s disease or a
related disorder? □ No

□ Yes

Have you ever been the main family caregiver for someone with Alzheim er’s disease or a
related disorder? □ No

□ Yes

Have you ever attended an Alzheimer’s disease or related disorder support group?
□ No

□ Yes

Have you ever attended a class or educational program about A lzheim er’s disease or a
related disorder? □ No

□ Yes

Does your paid job involve working with people who have Alzheim er’s disease or a
related disorder? □ No

□ Yes

Do you volunteer with people who have Alzheimer’s disease or a related disorder?
□ No

□ Yes
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From which of the following places have you obtained information about Alzheimer’s
disease and related disorders? (check all that apply)
□
□
□
□
□
□
□
□
□
□
□
□

family
friends and acquaintances
physicians or other health care professionals
Alzheimer’s Association
television or radio
books, newspapers, or magazines
religious leaders
MEDLINE, PubMed, or similar professional databases
other Internet or World Wide Web sites
academic journals
research conferences
other sources (please list):__________________________________________
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APPENDIX IV
FEAR OF ALZHEIMER’S DISEASE SCALE (FADS)
Instructions: Please indicate your level of agreement with each
statement by checking the appropriate box.
(Check one
Some
Often
Rarely
times
1 .1 am afraid o f getting Alzheimer’s
disease.
2. When I forget something, I am apt
to think that I am developing
Alzheimer’s disease.
3. My heart races or palpitates when
I think about getting Alzheimer’s
disease.
4 . 1 cannot sleep because I ’m
worrying about developing
Alzheimer’s disease.
5 . 1 would rather die than develop
Alzheimer’s disease.
6 . 1 am afraid of developing
Alzheimer’s disease because o f the
burden I would be for my family.
7. When I think about the possibility
o f developing Alzheimer’s disease, I
become nervous or anxious.
8. The more I learn about
Alzheimer’s disease, the more
fearful I become o f getting it.
9. When I misplace things, I
sometimes think that I may have
Alzheimer’s disease.
10.1 feel hot and even sweat when I
think about developing Alzheimer’s
disease.

□

□

□

P

□

□

■O ' / 7
□

□

□

□

u 'E i

□

□

□

□

□

□

□

□

□

□

□
□

:

□
□

□

□
□
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□

□

□
□

□

□

□

□

Always

o
:

q

Check one
Some
Ofteii
Never . Rarely
times
11. Developing Alzheimer’s disease
would be the worst thing to happen
to me.
12. Thinking about Alzheimer’s
disease makes me feel fatigued.
13.1 fear not recognizing family
members.
14.1 think that 1 will probably get
Alzheimer’s disease and it frightens
me.
15. Even though my memory is
good, I am still afraid o f developing
Alzheimer’s disease.
16. My hands become clammy when
I think about getting Alzheimer’s
disease.
1 7 .1 often have difficulty
concentrating because I ’m worrying
about developing Alzheimer’s
disease.
18. Developing Alzheimer’s disease
frightens me because I would
eventually lose all of my
independence.
19. Now that Alzheimer’s disease is
becoming more public with the
diagnosis o f popular T.V., movie,
and political figures (e.g., Charlton
Heston, Ronald Reagan), I am
becoming more afraid that I may
develop it.
2 0 .1 feel shaky when I think about
getting Alzheimer’s disease.
21. My appetite decreases when I
think about developing Alzheim er’s
disease.
2 2 .1 would rather have a painful
physical illness (e.g., cancer, AIDS)
than develop Alzheimer’s disease.
23. When I hear about others with
Alzheimer’s disease, I become
fearful that I will get it as well.

□

□

□

□

□

□

□

□

:

:

□

Always
□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□
□

□

□

□

□
□

□

□

□

□

□

□
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□

□

□

□

N ever:
24. I ’m afraid o f losing my
memories.
25. The older I get, the more fearful I
become that I may develop
Alzheim er’s disease.
2 6 .1 believe that Alzheimer’s
disease is one o f the worst diseases a
person could develop.
27. I worry about developing
Alzheimer’s disease more than I
worry about developing other
diseases.
28. I ’m afraid o f getting Alzheimer’s
disease because I would have to rely
on someone else to take care o f me.
29. The worse my memory becomes,
the more I fear that I may have
Alzheimer’s disease.
3 0 .1 sometimes think that I am
developing Alzheimer’s disease.

□

Check one
Some
Rarely
Often
times

Always

□

□

□

□

□

□

□

□

□
□
□
□

□
□

□

□

□
□

□
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□

o

□

□

APPENDIX V
MEMORY FUNCTIONING QUESTIONNAIRE (MFQ)
Instructions: This is a questionnaire about how you remember information. There are no
right or wrong answers. Circle a number between 1 and 7 that best reflects your judgment
about your memory. Think carefully about your responses, and try to be as realistic as
possible when you make them. Please answer all questions.___________________________
General Frequency of Forgetting
How would you rate your memory in terms o f the kinds o f problems that you have?
major problems
some minor problems
no problems
1
2
3
4
5
6
7
How often do these present a problem for you?
always
a. names
b. faces

1

c. appointments

2

3

2

3

1

2

e. performing household chores
f. directions to places

1

never

5

AH''

4

2

3

4

- :3

' 4'

3

4

g. phone numbers you’ve just checked
h. phone numbers you use frequently

1

2

3

,\/Tx

i. things people tell you
j. keeping up correspondence

1

k. personal dates (e.g., birthdays)

;
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5

6

5':::;

6

5

6

7

6

7

5

6

7

y 3;v

6

7

5

6

7

y:4:)'

'ÏT /'''

d. where you put things (e.g., keys)

sometimes

4
j/A ': ^

2
2

3

4

7
;

6
5

6

U g 'y

6

7

How often do these present a problem for you?
sometimes

always
1. words

:0 :i

2

1

2

m. going to the store and forgetting what
you wanted to buy

3

never

A4 ' ' ^

5

4

5

n. taking a test

6

7

6

7

' "5-

0.

beginning to do something and
forgetting What you were doing
p. losing the thread o f thought in
conversation
q. losing the thread o f thought in public
speaking
r. knowing whether you’ve already told
someone something

1

2

1

2

1

2

3

2

3

3

4

5

6

y
4

5

6

7

5

A # '-

7

As you are reading a novel, how often do you have trouble remembering what you have
read ...
always
sometimes
never
a. in the opening chapters, once you have
y ;ÿ - N ' t A ^ y ;T /ê y 7
Afinished the book
b. three or four chapters before the one you
1
2
4
6
3
5
7
are currently reading
c. the chapter before the one you are
' d'
7
A2y ; :y'3'A, 'A 4 :' \.5yC
currently reading
d. the paragraph just before the one you
1
2
7
3
4
5
6
are currently reading
e. the sentence before the one you are
3 : 4
5: / 6
7
2 '
currently reading
'

When you are reading a newspaper or magazine article, how often do you have trouble
remembering what you have read...
never
sometimes
a. in the opening paragraphs, once you
1
y.3'7:; ;■ 6
have finished the article
b. three or four paragraphs before the one
1
5
7
2
4
6
3
you are currently reading
c. the paragraph before the one you are
1 7^ '27^ -7 3 7" A 4 :y .
currently reading
d. three or four sentences before the one
1
2
4 '
5
6
7
3
you are currently reading
e. the sentence before the one you are
5:7 . # y ;'.7./
1 : 7v 37.: '7:4f
currently reading
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How well you remember things that occurred...
very bad

very good

fair

a. last month is

1

2

3

4

5

b. between 6 months and 1 year ago is

1

2

3

4

5

c. between 1 and 5 years ago is

1

2

3

d. between 6 and 10 years ago is

1

2

3

6

7
:'t

4

5

6

7
7

Seriousness o f Forgetting
When you actually forget in these situations, how serious o f a problem do you consider
memory failure to be? ...
very
not
serious
som ewhat serious
serious
a. names

2

b. faces
c. appointments
d. where you put things (e.g., keys)

1

2

; V f:

2

1

2

3

2

: ;3:

2

e. performing household chores
f. directions to places

1

g. phone numbers you’ve just checked
1

h. phone numbers used frequently
i. things people tell you

1

2

4

1. words

1

n. taking a test
beginning to do something and
forgetting what you were doing
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5

6

7

5

6

7

: '::'4y'

5

/y & y

7

3

4

5

6

7

3 r

4

/VS'A

6

7

3

4

5

6

7

4 y

5

6

4

5

6

y 5:':

6

5

6

3

4

2

3

2

:y 3 '$

1

2

3

4

1

2

3

4

m. going to the store and fbrgetting what
you wanted to buy

7:

4

y H ':- 7 : 3 - ' / :3.;-‘

k. personal dates (e.g., birthdays)

6

:

7 ,5 ::/ y 6 /7 ;\/;7/'

;:-3A:

',;1;A

j. keeping up correspondence

0.

2

3

7;5;7:

;r5 //- A'ô:.;
5

6

7
y

7
7

7y

7 //
7

'7:6'.:: / / j y :

When you actually forget in these situations, how serious o f a problem do you consider
memory failure to be? ...
very
not
serious
somewhat serious
serious
p. losing the thread o f thought in
1
7
2
3
4
5
6
conversation
q. losing the thread o f thought in public
1
2
4
6
7
3
5
speaking
r. knowing whether you’ve already told
1 .. 2 .
3
- 4 % 7' 5;.:: 6 .77/7/}/
someone something
Retrospective Functioning
How is your memory compared to the way it w as...
much
worse
a. 1 year ago?

1

2

b. 5 years ago?

1

2

c. 10 years ago?

1

d. 20 years ago?

1

2

e. when you were 18?

1

- 727.1-

7

much
better

same

7y37.7 7747} 7 6 % }7:6}7; /7:7/
4

5

6

7

77477

'7 # - '

6

777'7/'

3

4

5

6

7

3

: 47/

3
7/: 3^

7:76: }7 '7:7^77

77.3

Mnemonic Usage
How often do you use these techniques to remind yourself about things...
always
sometimes
a. keep an appointment book

7:-..f;7.'

2

1

37;

4

7 5

2

3

4

5

2

3

1

2

3

-./.:f 7:

.7 .-'2:yy./

1

2

3

4

5

6

7

7/7l.':..7.

2

%377

4

5

6

:;if\

1

2

3

4

5

6

1

b. write yourself reminder notes
c. make lists of things to do
d. make grocery lists
e. plan your daily schedule in advance
f. mental repetition
g. associations with other things

never

h. keep things you need to do in a
prominent place where you will notice
them
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77
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„

6
6

}..7',7
7

7/4:7}} 7:7 5 :7/.} :-U6y' 77-9'7X
4

5

7/4:7 :'774%

6

7

6

../':'7:

APPENDIX VI
KNOWLEDGE ABOUT ALZHEIMER’S DISEASE
Below are some statements about Alzheimer’s disease. Please read each statement
carefully and check whether you think the statement is True or False. If you aren’t sure
o f the right answer, make your best guess. It’s important to check an answer for every
statement even if you’re not completely sure of the answer.
Check One
I . An evaluation o f a person for Alzheimer’s disease typically
includes information from a physical exam, memory tests,
□ T ru e □ False
brain scans, and a history o f the symptoms.
2. People with Alzheimer’s disease are particularly prone to
□ T ru e
O False
depression.
3. In general, as people with Alzheimer’s disease get worse,
□ T ru e
□ False
they are more likely to wander and get lost.
4. Medications can permanently stop Alzheimer’s disease
□ T ru e
□ False
from getting worse.
5. More than 50% of people over the age o f 85 have
□ T ru e
□ False
Alzheim er’s disease.
6. It has been scientifically proven that mental exercise can
□ T ru e
□ False
prevent a person from getting Alzheimer’s disease.
7. After symptoms o f Alzheimer’s disease appear, the average
□ T ru e
□ False
life expectancy is 6 to 12 years.
8. When a person with Alzheimer’s disease becomes agitated,
a medical examination might reveal other health problems
□ T ru e
□ False
that caused the agitation.
9. People with Alzheimer’s disease do best with simple
□ T ru e
□ False
instructions giving one step at a time.
10. When people with Alzheimer’s disease begin to have
difficulty taking care o f themselves, caregivers should take
□ T rue
□ False
over right away.
11. If a person with Alzheimer’s disease becomes alert and
agitated at night, a good strategy is to try to make sure that
□ T rue
□ False
the person gets plenty of physical activity during the day.
12. in rare cases, people have recovered from Alzheimer’s
□ True □ False
disease.
13. Having a parent or sibling with Alzheimer’s disease
□ True □ False
increases the chance o f developing it.
14. People whose Alzheimer’s disease is not yet severe can
□ True □ False
benefit from psychotherapy for depression and anxiety.
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Check One
15. Some people with Alzheimer’s disease cannot recognize
their children when they see them.
16. Drivers in the early stages of Alzheimer’s disease have
more auto accidents than other older drivers.
17. A person suspected o f having Alzheimer’s disease should
be evaluated to rule out treatable disorders with similar
symptoms.
18. If trouble with memory and confused thinking appears
suddenly, it is likely due to Alzheimer’s disease.
19. Currently, the best way to diagnose Alzheimer’s disease is
with a blood test.
20. Most people with Alzheimer’s disease live in nursing
homes.
21. Poor nutrition can make the symptoms o f Alzheimer’s
disease worse.
22. People in their 30s can have Alzheimer’s disease.
23. Taking vitamin E may reduce a person’s risk o f developing
Alzheimer’s disease.
24. A person with Alzheimer’s disease becomes increasingly
likely to fall down as the disease gets worse.
25. If a person with Alzheimer’s disease follows the caregiver
all over the house, it is helpful to encourage the person with
Alzheimer’s disease to stay in one room.
26. When people with Alzheimer’s disease repeat the same
question or story several times, it is helpful to remind them
that they are repeating themselves.
27. Once people have Alzheimer’s disease, they are no longer
capable o f making informed decisions about their own care.
28. Eventually, a person with Alzheimer’s disease will need 24hour supervision.
29. Having high cholesterol may increase a person’s risk o f
developing Alzheimer’s disease.
30. Alzheimer’s disease can be caused by eating food that was
cooked in aluminum pots.
31. The percentage o f people over age 65 with Alzheimer’s
disease exceeds 10%.
32. Tremor or shaking o f the hands or arms is a common
symptom of people with Alzheimer’s disease.
33 . Symptoms o f severe depression can be mistaken for
symptoms o f Alzheimer’s disease.
34. Alzheimer’s disease is one type o f dementia.
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□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

/}Q»Triie7' □ False
□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ T rue

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

□ True

□ False

Check One
35. Trouble handling money or paying bills is a common early
□ True
symptom o f Alzheimer’s disease.
36. One symptom that can occur with Alzheimer’s disease is
□ True
believing that other people are stealing one’s things.
37. When a person has Alzheimer’s disease, using reminder
□ True
notes is a crutch that can contribute to decline.
38. Prescription drugs that prevent Alzheimer’s disease are
□ True
available.
39. Having high blood pressure may increase a person’s risk of
/O .True/;,
developing Alzheimer’s disease.
40. Genes can only partially account for the development of
□ True
Alzheimer’s disease.
41. It is safe for people with Alzheimer’s disease to drive, as
□ True
long as they have a companion in the car at all times.
42. People with Alzheimer’s disease do best when exposed to
□ True
new experiences and environments as often as possible.
43. People with Alzheimer’s disease have more problems
□ True
remembering things on some days than on others.
44. Alzheimer’s disease is a normal part o f aging, like gray hair
□ True
or wrinkles.
45. Alzheimer’s disease progresses at the same speed for
□ True
everyone.
46. Changes in personality may occur in people who have
□ True
Alzheimer’s disease.
47. Alzheimer’s disease cannot be cured.
48. Frequent forgetfulness is the most common early sign of
Alzheimer’s disease.
49. Most people with Alzheimer’s disease remember recent
events better than things that happened in the past.

□ False
□ False
□ False
□ False
□ False
O False
□ False
□ False
□ F alse
□ False
□ False
□ False

□ True

□ False

□ True

□ False

□ True

□ False

50. Circle any number between 1 and 10 to indicate how much knowledge you think you
have about Alzheimer’s disease and related disorders.
1

I know nothing
at all

7

I have some
knowledge
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8

10

I am very
knowledgeable

APPENDIX VII
GERIATRIC DEPRESSION SCALE (GDS)
Instructions: Please choose the best answer to describe how you’ve felt the last 2 weeks.
Check One
1. Are you basically satisfied with your life?
2. Have you dropped many of your activities and
interests?

v:;:-f3;Yes7 ;
□ Yes

3. Do you feel that your life is empty?

□ No

^

4. Do you often get bored?

7::%7}Q;No-

□ Yes

□ No

7 / //: □ Yes.

□ No

6. Are you bothered by thoughts you can’t get out
o f your head?

□ Yes

□ No

7. Are you in good spirits most o f the time?

□ Yes

□ No

8. Are you afraid that something bad is going to
happen to you?

□ Yes

□ No

9. Do you feel happy most of the time?

□ Yes

10. Do you often feel hopeless?

□ Yes

□ No

11. Do you often get restless and fidgety?

□ Yes

7 7 : q N o . .}

12. Do you prefer to stay at home, rather than
going out and doing new things?

□ Yes

□ No

13. Do you frequently worry about the future?

□ Yes

5. Are you hopeful about the future?
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Check One
14. Do you feel you have more problems with
memory than most?

□ Yes

7; {q /N o

15. Do you think it is worthwhile to be alive now?

□ Yes

□ No

16. Do you often feel downhearted and blue?

□ Yes

□ No

17. Do you feel pretty worthless the way you are
now?

□ Yes

□ No

18. Do you worry a lot about the past?

□ Yes

□ No

19. Do you find life very exciting?

□ Yes

□ No

20. Is it hard for you to get started on new projects?

□ Yes

21. Do you feel full of energy?

□ Yes

□ No

22. Do you feel that your situation is hopeless?

□ Yes

/; :% q /N o

23. Do you think that most people are better off
than you are?

□ Yes

□ No

24. Do you frequently get upset over little things?

□ Yes

□ No

25. Do you frequently feel like crying?

□ Yes

□ No

26. Do you have trouble concentrating?

□ Yes

□ No

27. Do you enjoy getting up in the morning?

□ Yes

□ No

28. Do you prefer to avoid social gatherings?

□ Yes

□ No

29. Is it easy for you to make decisions?

□ Yes

□ No

30. Is your mind as clear as it used to be?

□ Yes

□ No
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